Composition containing lipid peptide and sucrose ester
Patent Information
- Application Number
- JP2022559273
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-10-29
- Filing Date
- 2021-10-29
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2041-10-29
AI Technical Summary
Current products fail to effectively prevent the adhesion of pollutants such as dust, pollen, and particulate matter to skin and hair surfaces, leading to skin irritation and allergic symptoms, and there is a lack of materials that can form a protective film using gel-like substances with polypeptides.
A composition containing a lipid peptide and sucrose ester is formed, which creates a film on the skin or hair surface, preventing the adhesion of pollutants and promoting skin penetration, with specific compounds like lauroyl-Gly-His and sucrose esters used to achieve this.
The composition effectively prevents contamination by pollutants, reduces skin irritation, and promotes skin penetration while being safe for use due to its biosafety and low molecular weight, providing a protective barrier against fine particulate matter like PM2.5 and allergens.
Smart Images

Figure 2022092284000001 
Figure 2022092284000002 
Figure 2022092284000003
Abstract
Description
Composition containing lipid peptide and sucrose ester
[0001] The present invention relates to a composition containing a lipid peptide and a sucrose ester, and more particularly to a composition that forms a film on the surface of the skin or hair, thereby preventing the adhesion of dust, pollen, particulate matter, etc., and promoting skin penetration.
[0002] In recent years, interest in harmful substances such as allergens (e.g., pollen) and fine particulate matter (e.g., PM2.5) has increased. To prevent these substances from being absorbed into the human body, various products, including masks, have been developed. Among these products, products designed to prevent the adhesion of harmful substances to the body or clothing by spraying or other methods have been proposed. For example, a pollen adsorption inhibitor containing a polymer containing a monomer unit having a specific zwitterionic or anionic group as a constituent unit (Patent Document 1) and a harmful substance adhesion inhibitor containing hydroxyalkyl chitosan (Patent Document 2) have been proposed.
[0003] Meanwhile, in the fields of cosmetics and hair styling products, films formed on the skin or hair surface provide an effective barrier on the skin or hair surface, thereby playing various important roles in personal care products, such as suppressing evaporation of moisture from the skin or hair and enhancing the retention of active ingredients that are absorbed transdermally or penetrate into the hair. For example, skin care preparations that exhibit high moisturizing effects include film-forming cosmetics with a self-assembled structure, such as those using layered α-gel (Patent Document 3). Furthermore, hair preparations using polypeptides have been proposed to reduce hair damage caused by heat treatments such as brushing or using a hair dryer (Patent Documents 4 and 5).
[0004] Japanese Patent No. 4562585 Japanese Patent No. 6198799 Japanese Patent Application Laid-Open No. 2016-6030 Japanese Patent Application Laid-Open No. 10-77210 Japanese Patent Application Laid-Open No. 2002-308756
[0005] To date, there have been no reports of materials that use polypeptide gels to prevent adhesion of dust, pollen, particulate matter, etc. to hair or skin surfaces. The object of the present invention is to provide a new composition that forms a film on the skin or hair surface to prevent adhesion of pollutants, prevent contamination of the skin and hair surface by such substances, and promote skin penetration.
[0006] The present inventors have discovered that a composition containing at least one lipid peptide-type compound and a sucrose ester forms a film on the surface of the skin or hair, thereby preventing the adhesion of pollutants and promoting skin penetration, and have completed the present invention.
[0007] That is, in a first aspect, the present invention relates to a composition containing a lipid peptide-type compound, in which a peptide moiety formed by repeating at least two or more identical or different amino acids is bound to a lipid moiety consisting of an aliphatic group having 10 to 24 carbon atoms, and a sucrose ester. In a second aspect, the present invention relates to the composition according to the first aspect, which is capable of forming a film on the surface of skin or hair. In a third aspect, the present invention relates to a composition according to the first or second aspect, which prevents the adhesion of dust, pollen, particulate matter, mites (including corpses), gaseous substances, or odorous substances to the surface of skin or hair. In a fourth aspect, the present invention relates to the composition according to any one of the first to third aspects, wherein the lipid peptide-type compound is at least one of compounds represented by the following formulas (1) to (3) or pharmaceutically usable salts thereof: (In the formula, R 1 represents an aliphatic group having 9 to 23 carbon atoms; R 2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, which may have a branched chain having 1 or 2 carbon atoms; R 3 Ha-(CH 2 ) n represents an —X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, or —CONH 2 a 5-membered ring group or a 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring. (In the formula, R 4represents an aliphatic group having 9 to 23 carbon atoms; R 5 ~R 7 are each independently a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may have a branched chain and which has 1 or 2 carbon atoms, or —(CH 2 ) n represents an —X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, or —CONH 2 a 5-membered ring group or a 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring. (In the formula, R 8 represents an aliphatic group having 9 to 23 carbon atoms; R 9 ~R 12 are each independently a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may have a branched chain and which has 1 or 2 carbon atoms, or —(CH 2 ) n represents an —X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, or —CONH 2(1) represents a group, or a 5-membered or 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring.) A fifth aspect relates to a method for preventing contamination of a skin surface or a hair surface, comprising a film-forming step of forming on the skin surface or hair surface a film comprising a composition containing a lipid peptide-type compound, in which a peptide portion formed by repeating at least two or more identical or different amino acids is bound to a lipid portion composed of an aliphatic group having 10 to 24 carbon atoms, and a sucrose ester. A sixth aspect relates to the method according to the fifth aspect, in which the lipid peptide-type compound comprises at least one of the compounds represented by formulas (1) to (3) or pharmaceutically acceptable salts thereof. As a seventh aspect, the present invention relates to a method for preventing adhesion of dust, pollen, particulate matter, mites (including corpses), gaseous substances, or odorous substances to the skin or hair surface, the method comprising a film-forming step of forming a film on the skin or hair surface, the film comprising a composition containing a lipid peptide-type compound, in which a peptide moiety formed by repeating at least two or more identical or different amino acids is bound to a lipid moiety formed by an aliphatic group having 10 to 24 carbon atoms, and a sucrose ester. As an eighth aspect, the present invention relates to the method according to the seventh aspect, wherein the lipid peptide-type compound comprises at least one of the compounds represented by formulas (1) to (3) or pharmaceutically acceptable salts thereof. As a ninth aspect, the present invention relates to a composition for enhancing skin penetration, the composition comprising a lipid peptide-type compound, in which a peptide moiety formed by repeating at least two or more identical or different amino acids is bound to a lipid moiety formed by an aliphatic group having 10 to 24 carbon atoms, and a sucrose ester. As a tenth aspect, a method for promoting skin penetration, comprising a film-forming step of forming a film on the surface of skin or hair, the film comprising a composition containing a lipid peptide compound, in which a peptide moiety formed by repeating at least two or more identical or different amino acids is bound to a lipid moiety formed by an aliphatic group having 10 to 24 carbon atoms, and a sucrose ester.As an eleventh aspect, the composition according to any one of the second to fourth aspects, wherein the surface of the coating has roughness, and the average surface roughness is 3 nm to 500 nm.
[0008] According to the present invention, a composition containing a specific lipid peptide-type compound and a sucrose ester forms a film on the surface of skin or hair, thereby preventing the adhesion of dust, pollen, particulate matter, etc., and preventing skin or hair contamination by these substances. Furthermore, according to the present invention, the composition can prevent the adhesion of dust, pollen, particulate matter, etc., thereby suppressing skin irritation and other problems that may be caused by these substances, and avoiding problems such as inflammation, oxidation, and skin aging. Furthermore, according to the present invention, the adhesion of fine particulate matter such as pollen and PM2.5 can be prevented, thereby preventing the introduction of pollutants into homes, etc., which may occur when these substances are transported while still attached to skin or hair, and preventing the inhalation of these substances, and is expected to suppress the occurrence of allergic symptoms caused by these substances. Furthermore, according to the present invention, the adhesion of unpleasant odors such as cigarette smoke and odorous substances to the surface of skin or hair can be prevented. Furthermore, the lipid peptide-type compound used in the composition of the present invention is an extremely safe artificial low-molecular-weight compound composed only of lipids and peptides. Of course, sucrose esters are also highly stable substances for living organisms. Therefore, the material of the present invention is highly safe for the living body and is extremely useful in the above-mentioned applications from the viewpoint of the high level of safety required for pharmaceutical and cosmetic applications. Furthermore, compared to conventionally proposed products for preventing the adsorption and adhesion of pollen, etc., the present invention utilizes a film composed of a composition containing a low-molecular-weight lipid peptide compound and a sucrose ester, and therefore, when a film is formed by application to the skin or hair, it can promote skin penetration and provide a good feel when used.
[0009] 1 is an image obtained by observing PM2.5 particles attached to a support tray coated with the aqueous dispersion of Examples 24, 27, and Comparative Example 3 using a microscope VHX-2000. This is a graph showing the area ratio of PM2.5 particles in an image obtained by observing PM2.5 particles attached to a support tray coated with the aqueous dispersion of Examples 22 to 27 and Comparative Example 3 using a microscope VHX-2000. This is a graph showing the results of quantifying pollen attached to a support tray coated with the solutions of Examples 22 to 27 and Comparative Example 3 using an ITEA cedar pollen allergen (Cryj1) ELISA kit. This is an image obtained by observing cedar pollen attached in Examples 22, 24, and Comparative Example 3 using a scanning electron microscope. This is a graph showing the amount of nicotinamide in skin extracts extracted from the three-dimensional cultured epidermal models of Examples 29 to 34 and Comparative Example 3. This is a graph showing the amount of nicotinamide detected in the reservoirs of Examples 29 to 34 and Comparative Example 3. 1 is a graph showing the amount of nicotinamide detected in skin extracts extracted from the three-dimensional cultured epidermal models of Examples 39 to 42 and Comparative Example 3. FIG. 1 is a graph showing the amount of nicotinamide detected in the reservoirs of Examples 39 to 42 and Comparative Example 3. FIG. 2 is a photograph showing the observation of adhered pollen in Comparative Examples 4, 5, 43, and 44. FIG. 3 is a graph showing the results of quantifying pollen adhered to the artificial leather Suprare using an ITEA cedar pollen allergen (Cryj1) ELISA kit in Comparative Examples 4, 43, and 44. FIG. 4 is a photograph showing the observation of adhered PM2.5 particles in Comparative Examples 4, 5, 43, and 44. FIG. 5 is a graph showing the amount of metal elements contained in PM2.5 particles adhered to the artificial leather Suprare in Comparative Example 4 and Example 44. FIG. 6 is a photograph of the device used to spray PM2.5 particles onto the artificial leather Suprare in Comparative Example 4 and Example 44. 1 is a graph showing the amount of silicon contained in PM2.5 particles adhering to artificial leather Suprale in Comparative Example 4 and Example 44. 2 is a graph showing the amount of metal elements contained in PM2.5 particles adhering to artificial leather Suprale when the composition is sprayed and then dried in Comparative Example 5 and Example 44.1 is an image obtained by observation with a scanning electron microscope of a film formed on the surface of artificial leather Suprare sprayed with the solution of Example 44.
[0033] FIG. 1 is a graph showing the results of quantifying Derf1 contained in house dust mites attached when the solutions of Comparative Example 5 and Example 44 were added to artificial leather Suprare and dried.
[0034] FIG. 1 is a photograph showing the results of observation of house dust mites attached when the solutions of Comparative Example 5 and Example 44 were added to artificial leather Suprare and dried.
[0035] FIG. 1 is a diagram showing the results of measuring the roughness of the film surface using an atomic force microscope (AFM) after the solutions of Comparative Example 5 and Example 44 were added to a silicon wafer and dried.
[0036] FIG. 1 is a graph showing the amount of retinol detected in skin extracts extracted from the three-dimensional cultured epidermal models of Comparative Example 6 and Example 45.
[0037] FIG. 1 is a graph showing the amount of ascorbic acid glycoside detected in skin extracts extracted from the three-dimensional cultured epidermal models of Comparative Example 7 and Example 46. 1 is a photograph of Gobi yellow sand particles adhered in Comparative Example 8, Example 47, and Example 48. FIG. 2 is a graph showing the amount of metal elements contained in Gobi yellow sand particles adhered to artificial leather Suprale in Comparative Example 8, Example 47, and Example 48. FIG. 3 is a graph showing the amount of nicotinamide detected in reservoirs in Examples 49 to 52 and Comparative Example 9. FIG. 4 is a graph showing the amount of nicotinamide detected in reservoirs in Example 53 and Comparative Example 10. FIG. 5 is a photograph of PM2.5 particles adhered in Comparative Example 11 and Example 54.
[0010] The present invention relates to a composition containing a specific lipid peptide-type compound and a sucrose ester. The composition of the present invention can form a film on the surface of skin or hair, thereby preventing the adhesion of pollutants such as dust to the skin and hair surfaces, preventing contamination by these substances (anti-pollution effect), and promoting skin penetration. Target substances to be prevented from adhering to and contaminating the skin and hair surfaces include dust, pollen, air pollutants such as exhaust gases and factory smoke, particulate matter contained in cigarette smoke (PM10, suspended particulate matter (SPM), PM2.5 (fine particulate matter, etc.)), gaseous substances (SOx, CO, etc.), odorous substances, as well as allergens such as house dust and fungi, mites (including dead mites), and viruses such as influenza viruses. Each component is described below.
[0011] [Composition] [Lipid peptide type compound] The lipid peptide type compound used in the composition of the present invention has a lipid portion consisting of an aliphatic group having 10 to 24 carbon atoms (the total number of carbon atoms in the lipid portion is 10 to 24), to which a peptide portion formed by repeating at least two or more identical or different amino acids is bound. For example, compounds (lipid peptides) represented by the following formulas (1) to (3) or pharmaceutically usable salts thereof (low molecular weight compounds having a lipid portion as a hydrophobic portion and a peptide portion as a hydrophilic portion) can be used.
[0012]
[0013] In the above formula (1), R 1 represents an aliphatic group having 9 to 23 carbon atoms, and preferably R 1 R is preferably a linear aliphatic group having 11 to 23 carbon atoms and which may have 0 to 2 unsaturated bonds. 1and an adjacent carbonyl group. Specific examples of the lipid moiety (acyl group) composed of a lauroyl group, a dodecylcarbonyl group, a myristoyl group, a tetradecylcarbonyl group, a palmitoyl group, a margalloyl group, an oleoyl group, an elideyl group, a linoleoyl group, a stearoyl group, a vaccenoyl group, an octadecylcarbonyl group, an arachidoyl group, an eicosylcarbonyl group, a behenoyl group, an elcanoyl group, a docosylcarbonyl group, a lignoceyl group, a nervonoyl group, and the like can be mentioned. Particularly preferred are a lauroyl group, a myristoyl group, a palmitoyl group, a margalloyl group, a stearoyl group, an oleoyl group, an elideyl group, and a behenoyl group.
[0014] In the above formula (1), R contained in the peptide portion 2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms. The alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms means an alkyl group having 1 to 4 carbon atoms in the main chain and which may have a branched chain having 1 or 2 carbon atoms, and specific examples thereof include a methyl group, an ethyl group, an n-propyl group, an i-propyl group, an n-butyl group, an i-butyl group, a sec-butyl group, and a tert-butyl group. 2 is preferably a hydrogen atom or an alkyl group of 1 to 3 carbon atoms which may have a branched chain of 1 carbon atom, and more preferably a hydrogen atom. The alkyl group of 1 to 3 carbon atoms which may have a branched chain of 1 carbon atom means an alkyl group having 1 to 3 carbon atoms in the main chain and which may have a branched chain of 1 carbon atom, and specific examples thereof include a methyl group, an ethyl group, an n-propyl group, an i-propyl group, an i-butyl group, and a sec-butyl group, and preferably a methyl group, an i-propyl group, an i-butyl group, or a sec-butyl group.
[0015] In the above formula (1), R 3 Ha-(CH 2 )n-X group. 2 In the n-X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, or —CONH 2group, a 5-membered ring group or a 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring. 3 Representing -(CH 2 In the n-X group, X is preferably an amino group, a guanidino group, a carbamoyl group (-CONH 2 group), a pyrrole group, an imidazole group, a pyrazole group or an indole group, and more preferably an imidazole group. 2 In the —(CH )n-X group, n is preferably 1 or 2, and more preferably 1. 2 ) The n-X group preferably represents an aminomethyl group, a 2-aminoethyl group, a 3-aminopropyl group, a 4-aminobutyl group, a carbamoylmethyl group, a 2-carbamoylethyl group, a 3-carbamoylbutyl group, a 2-guanidinoethyl group, a 3-guanidinobutyl group, a pyrrolemethyl group, a 4-imidazolemethyl group, a pyrazolemethyl group, or a 3-indolemethyl group, more preferably a 4-aminobutyl group, a carbamoylmethyl group, a 2-carbamoylethyl group, a 3-guanidinobutyl group, a 4-imidazolemethyl group, or a 3-indolemethyl group, and even more preferably a 4-imidazolemethyl group.
[0016] Particularly suitable lipid peptides in the compound represented by formula (1) as lipid peptide compounds are compounds formed from the following lipid portion and peptide portion (amino acid assembly portion): alanine (Ala), asparagine (Asn), glutamine (Gln), glycine (Gly), histidine (His), isoleucine (Ile), leucine (Leu), lysine (Lys), tryptophan (Trp), and valine (Val). : Lauroyl-Gly-His, Lauroyl-Gly-Gln, Lauroyl-Gly-Asn, Lauroyl-Gly-Trp, Lauroyl-Gly-Lys, Lauroyl-Ala-His, Lauroyl-Ala-Gln, Lauroyl-Ala-Asn, Lauroyl-Ala-Trp, Lauroyl-Ala-Lys; Myristoyl-Gly-His, Myristoyl-Gly-Gln, Myristoyl-Gly-Asn, Myristoyl-Gly-Trp, Myristoyl-Gly-Lys, Myristoyl-Ala-His, Myristoyl-Ala-Gln, Myristoyl-Ala-Asn, Myristoyl-Ala-Trp, Myristoyl-Ala-Lys; Palmitoyl palmitoyl-Gly-His, palmitoyl-Gly-Gln, palmitoyl-Gly-Asn, palmitoyl-Gly-Trp, palmitoyl-Gly-Lys, palmitoyl-Ala-His, palmitoyl-Ala-Gln, palmitoyl-Ala-Asn, palmitoyl-Ala-Trp, palmitoyl-Ala-Lys; Stearoyl-Gly-His, stearoyl-Gly-Gln, stearoyl-Gly-Asn, stearoyl-Gly-Trp, stearoyl-Gly-Lys, stearoyl-Ala-His, stearoyl-Ala-Gln, stearoyl-Ala-Asn, stearoyl-Ala-Trp, stearoyl-Ala-Lys.
[0017] Most preferred are lauroyl-Gly-His, lauroyl-Ala-His, myristoyl-Gly-His, myristoyl-Ala-His, palmitoyl-Gly-His, palmitoyl-Ala-His, stearoyl-Gly-His, and stearoyl-Ala-His.
[0018]
[0019] In the above formula (2), R 4 represents an aliphatic group having 9 to 23 carbon atoms, and preferred examples thereof include the above-mentioned R 1 In the above formula (2), R 5 ~R 7 are each independently a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may have a branched chain and which has 1 or 2 carbon atoms, or —(CH 2 ) represents an n-X group, preferably R 5 ~R 7 At least one of the following is -(CH 2 ) represents an n-X group, where n is a number from 1 to 4, and X represents an amino group, a guanidino group, or —CONH 2 group, a 5-membered or 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring. 5 ~R 7 Preferred examples of R 2 and R 3 The same groups as defined above are included.
[0020] In the compound represented by the above formula (2), preferred lipid peptides are compounds formed from the following lipid portion and peptide portion (amino acid assembly portion): lauroyl-Gly-Gly-His, myristoyl-Gly-Gly-His, myristoyl-Gly-Gly-Gln, myristoyl-Gly-Gly-Asn, myristoyl-Gly-Gly-Trp, myristoyl-Gly-Gly-Lys, myristoyl-Gly-Ala-His, myristoyl-Gly-Ala-Gln, myristoyl-Gly-Ala-Asn, Myristoyl-Gly-Ala-Trp, myristoyl-Gly-Ala-Lys, myristoyl-Ala-Gly-His, myristoyl-Ala-Gly-Gln, myristoyl-Ala-Gly-Asn, myristoyl-Ala-Gly-Trp, myristoyl-Ala-Gly-Lys, myristoyl-Gly-His-Gly, myristoyl-His-Gly-Gly, Palmitoyl-Gly-Gly-His, palmitoyl-Gly-Gly-Gln, palmitoyl-Gly-Gly-Asn, palmitoyl-Gly-Gly-Trp, palmitoyl-Gly-Gly-Lys, palmitoyl-Gly-Ala-His, palmitoyl-Gly-Ala-Gln, palmitoyl-Gly-Ala-Asn, palmitoyl-Gly-Ala-Trp, Palmitoyl-Gly-Ala-Lys, palmitoyl-Ala-Gly-His, palmitoyl-Ala-Gly-Gln, palmitoyl-Ala-Gly-Asn, palmitoyl-Ala-Gly-Trp, palmitoyl-Ala-Gly-Lys, palmitoyl-Gly-His-Gly, palmitoyl-His-Gly-Gly, stearoyl-Gly-Gly-His.
[0021] Of these, most preferred are lauroyl-Gly-Gly-His, myristoyl-Gly-Gly-His, palmitoyl-Gly-Gly-His, palmitoyl-Gly-His-Gly, palmitoyl-His-Gly-Gly, and stearoyl-Gly-Gly-His.
[0022]
[0023] In the above formula (3), R8 represents an aliphatic group having 9 to 23 carbon atoms, and preferred examples thereof include the above-mentioned R 1 In the above formula (3), R 9 ~R 12 are each independently a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may have a branched chain and which has 1 or 2 carbon atoms, or —(CH 2 ) represents an n-X group, preferably R 9 ~R 12 At least one of the following is -(CH 2 ) represents an n-X group, where n is a number from 1 to 4, and X represents an amino group, a guanidino group, or —CONH 2 group, a 5-membered or 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring. 9 ~R 12 Preferred examples of R 2 and R 3 The same groups as defined above are included.
[0024] Therefore, in the compound represented by the above formula (3), preferred lipid peptide compounds, particularly preferred lipid peptides, include lauroyl-Gly-Gly-Gly-His, myristoyl-Gly-Gly-Gly-His, palmitoyl-Gly-Gly-Gly-His, palmitoyl-Gly-Gly-His-Gly, palmitoyl-Gly-His-Gly-Gly, palmitoyl-His-Gly-Gly, palmitoyl-His-Gly-Gly, stearoyl-Gly-Gly-Gly-His, and the like.
[0025] In the present invention, the amount of the lipid peptide compound is, for example, 0.001% to 30% by mass, preferably 0.005% to 10% by mass, more preferably 0.01% to 5% by mass, and even more preferably 0.05% to 1% by mass, relative to the total mass of the composition. The lipid peptide compound used in the present invention consists of at least one of the compounds (lipopeptides) represented by the above formulas (1) to (3) or pharmaceutically acceptable salts thereof, and these compounds can be used alone or in combination of two or more.
[0026] [Sucrose Ester] In the present invention, examples of sucrose esters include sucrose caprate, sucrose laurate, sucrose myristate, sucrose palmitate, sucrose stearate, sucrose oleate, sucrose arachidate, and sucrose behenate. Particularly preferred sucrose esters include sucrose laurate, sucrose myristate, sucrose palmitate, and sucrose stearate.
[0027] In the present invention, the amount of sucrose ester to be blended is, for example, 0.001 to 20% by mass, preferably 0.005 to 10% by mass, more preferably 0.01 to 10% by mass, even more preferably 0.05 to 5% by mass, and particularly preferably 0.1 to 1% by mass, relative to the total mass of the composition. The sucrose ester used in the present invention is at least one of the above sucrose esters, and these sucrose esters can be used alone or in combination of two or more.
[0028] [Other Components] The composition of the present invention may contain water, alcohol, polyhydric alcohol or a mixed solution thereof in addition to the lipid peptide type compound and sucrose ester.
[0029] Examples of the water include purified water, purified water, hard water, soft water, natural water, deep sea water, electrolytic alkaline ionized water, electrolytic acidic ionized water, ionized water, and cluster water.
[0030] The alcohol is a monohydric alcohol, and examples thereof include alcohols having 1 to 6 carbon atoms that dissolve in water in any proportion, specifically methanol, ethanol, 2-propanol, and i-butanol, as well as higher alcohols, specifically oleyl alcohol and phenoxy alcohol.
[0031] The polyhydric alcohol is a dihydric or higher alcohol, and examples thereof include propylene glycol, 1,3-butanediol, 2-ethyl-1,3-hexanediol, glycerin, isopentyldiol, ethylhexanediol, erythrulose, ozonated glycerin, caprylyl glycol, glycol, (C15-18) glycol, (C20-30) glycol, diethylene glycol, diglycerin, dithiaoctanediol, DPG, thioglycerin, 1,10-decanediol, decylene glycol, triethylene glycol, methylhydroxymethylcyclohexanol, phytantriol, phenoxypropanediol, 1,2-butanediol, 2,3-butanediol, butylethylpropanediol, 1,2-hexanediol, hexylene glycol, pentylene glycol, methylpropanediol, menthanediol, lauryl glycol, and polypropylene glycol.
[0032] In the present invention, when a polyhydric alcohol is contained, the content thereof can be, for example, 0.001 to 10% by mass, preferably 0.001 to 5% by mass, and more preferably 0.005 to 0.5% by mass, relative to the total mass of the composition. In the present invention, when a polyhydric alcohol is contained, the polyhydric alcohol can be used alone or in combination of two or more types.
[0033] [Other Additives] The composition of the present invention may contain additives that can be generally used as cosmetic additives, quasi-drug additives, and pharmaceutical additives, as needed. Examples of additive components such as physiologically active substances and functional substances that can be incorporated into external skin preparations such as cosmetics, quasi-drugs, and pharmaceuticals include pigments, oily bases, moisturizing agents, texture improvers, surfactants other than those mentioned above, polymers, thickeners, gelling agents, solvents, antioxidants, reducing agents, oxidizing agents, preservatives, antibacterial agents, disinfectants, chelating agents, pH adjusters, acids, alkalis, powders, inorganic salts, UV absorbers, whitening agents, vitamins and their derivatives, hair growth agents, whitening agents, and the like. Examples of such additives include hair preventative agents, blood circulation promoters, stimulants, hormones, anti-wrinkle agents, anti-aging agents, tightening agents, cooling agents, warming agents, wound healing promoters, irritation alleviators, analgesics, cell activators, plant / animal / microbial extracts, antipruritics, exfoliating / dissolving agents, antiperspirants, cooling agents, astringents, enzymes, nucleic acids, fragrances, pigments, colorants, dyes, anti-inflammatory agents, anti-asthmatic agents, anti-chronic obstructive pulmonary disease agents, anti-allergic agents, immunomodulators, anti-infective agents, and anti-fungal agents. The content of these other additives may vary depending on the type, but may be, for example, about 0.001 to 20% by mass, or about 0.01 to 10% by mass, based on the total mass of the composition.
[0034] inorganic black pigments such as black iron oxide and low-order titanium oxide; inorganic purple pigments such as mango violet and cobalt violet; inorganic green pigments such as chromium oxide, chromium hydroxide and cobalt titanate; inorganic blue pigments such as ultramarine and Prussian blue; pearl pigments such as titanium oxide-coated mica, titanium oxide-coated bismuth oxychloride, titanium oxide-coated talc, colored titanium oxide-coated mica, bismuth oxychloride and fish scale leaf; extender pigments such as talc, sericite, mica, kaolin, calcium carbonate, magnesium carbonate, silicic anhydride, barium sulfate and aluminum hydroxide; metal powder pigments such as aluminum powder, copper powder and gold; surface-treated inorganic and metal powder pigments; organic pigments such as zirconium, barium or aluminum lake;
[0035] Examples of oily bases include higher (polyhydric) alcohols such as oleyl alcohol, jojoba alcohol, chimyl alcohol, selachyl alcohol, batyl alcohol, hexyldecanol, isostearyl alcohol, 2-octyldodecanol, and dimer diol; aralkyl alcohols such as benzyl alcohol and derivatives thereof; stearic acid, isostearic acid, behenic acid, undecylenic acid, 12-hydroxystearic acid, palmitoleic acid, oleic acid, linoleic acid, linolenic acid, erucic acid, docosahexaenoic acid, eicosapentaenoic acid, and isohe xadecanoic acid, anteisohenicosanoic acid, long-chain branched fatty acids, dimer acids, hydrogenated dimer acids, etc.; hydrocarbons such as liquid paraffin (mineral oil), heavy liquid isoparaffin, light liquid isoparaffin, α-olefin oligomer, polyisobutene, hydrogenated polyisobutene, polybutene, squalane, olive-derived squalane, squalene, petrolatum, and solid paraffin; candelilla wax, carnauba wax, rice wax, Japan wax, beeswax, montan wax, ozokerite, ceresin, paraffin wax, and microcrystalline Waxes such as petrolatum, Fischer-Tropsch wax, polyethylene wax, and ethylene-propylene copolymer; coconut oil, palm oil, palm kernel oil, safflower oil, olive oil, castor oil, avocado oil, sesame oil, tea oil, evening primrose oil, wheat germ oil, macadamia nut oil, hazelnut oil, kukui nut oil, rosehip oil, meadowfoam oil, persic oil, tea tree oil, peppermint oil, corn oil, rapeseed oil, sunflower oil, wheat germ oil, linseed oil, cottonseed oil, soybean oil, peanut oil, rice bran oil, cocoa butter, shea butter, hydrogenated yam Vegetable oils and fats such as oat oil, hydrogenated castor oil, jojoba oil, hydrogenated jojoba oil, grapeseed oil, apricot oil (almond oil), and camellia oil; animal oils and fats such as beef tallow, milk fat, horse fat, egg yolk oil, mink oil, and turtle oil; animal waxes such as whale wax, lanolin, and orange roughy oil; lanolins such as liquid lanolin, reduced lanolin, adsorbed and purified lanolin, acetated lanolin, acetated liquid lanolin, hydroxylanolin, polyoxyethylene lanolin, lanolin fatty acids, hard lanolin fatty acids, lanolin alcohol, acetated lanolin alcohol, and cetyl lanolyl acetate esters;Sterols such as cholesterol, dihydrocholesterol, lanosterol, dihydrolanosterol, phytosterol, cholic acid, etc.; sapogenins; saponins; cholesteryl acetate, cholesteryl nonanoate, cholesteryl stearate, cholesteryl isostearate, cholesteryl oleate, N-lauroyl-L-glutamic acid di(cholesteryl / behenyl / octyldodecyl), N-lauroyl-L-glutamic acid di(cholesteryl / octyldodecyl), N-lauroyl-L-glutamic acid di(phytosteryl / behenyl / octyldodecyl), N-lauroyl acyl sarcosine alkyl esters such as di(phytosteryl / octyldodecyl)-L-glutamate and N-lauroyl sarcosine isopropyl, sterol esters such as cholesteryl 12-hydroxystearate, cholesteryl macadamia nut oil fatty acid, phytosteryl macadamia nut oil fatty acid, phytosteryl isostearate, cholesteryl soft lanolin fatty acid, cholesteryl hard lanolin fatty acid, cholesteryl long-chain branched fatty acid, and cholesteryl long-chain α-hydroxy fatty acid; lipid complexes such as phospholipid-cholesterol complexes and phospholipid-phytosterol complexes;Octyldodecyl myristate, hexyldecyl myristate, octyldodecyl isostearate, cetyl palmitate, octyldodecyl palmitate, cetyl octanoate, hexyldecyl octanoate, isotridecyl isononanoate, isononyl isononanoate, octyl isononanoate, isodecyl neopentanoate, isotridecyl neopentanoate, isostearyl neopentanoate, octyldodecyl neodecanoate, oleyl oleate, octyldodecyl oleate, octyldodecyl ricinoleate, octyldodecyl lanolinate, hexyldecyl dimethyloctanoate, octyl erucate Monoalcohol carboxylic acid esters such as tildodecyl, hydrogenated castor oil isostearate, ethyl oleate, avocado oil fatty acid ethyl, isopropyl myristate, isopropyl palmitate, octyl palmitate, isopropyl isostearate, isopropyl lanolin fatty acid, diethyl sebacate, diisopropyl sebacate, dioctyl sebacate, diisopropyl adipate, dibutyloctyl sebacate, diisobutyl adipate, dioctyl succinate, and triethyl citrate; oxyacid esters such as cetyl lactate, diisostearyl malate, and hydrogenated castor oil monoisostearate;Glyceryl trioctanoate (glyceryl tri-2-ethylhexanoate), glyceryl trioleate, glyceryl triisostearate, glyceryl diisostearate, caprylic / capric triglyceride, caprylic / capric / myristic / stearic triglyceride, hydrogenated rosin triglyceride (hydrogenated ester gum), rosin triglyceride (ester gum), glyceryl behenate eicosandioate, trimethylolpropane trioctanoate, trimethylolpropane triisostearate, diisostearate Neopentyl glycol octanoate, neopentyl glycol dicaprate, 2-butyl-2-ethyl-1,3-propanediol dioctanoate, propylene glycol dioleate, pentaerythrityl tetraoctanoate, pentaerythrityl hydrogenated rosin, ditrimethylolpropane triethylhexanoate, ditrimethylolpropane isostearate / sebacic acid, pentaerythrityl triethylhexanoate, dipentaerythrityl hydroxystearate / stearic acid / rosin acid, diglyceride diisostearate Polyhydric alcohol fatty acid esters such as lyceryl, polyglyceryl tetraisostearate, polyglyceryl-10 nonaisostearate, deca(erucic acid / isostearate / ricinoleic acid)polyglyceryl-8, (hexyldecanoic acid / sebacic acid) diglyceryl oligoester, glycol distearate (ethylene glycol distearate), 3-methyl-1,5-pentanediol dineopentanoate, 2,4-diethyl-1,5-pentanediol dineopentanoate; diisopropyl dimer dilinoleate, dimer Derivatives of dimer acid or dimer diol such as diisostearyl dimer dilinoleate, di(isostearyl / phytosteryl) dimer dilinoleate, (phytosteryl / behenyl) dimer dilinoleate, (phytosteryl / isostearyl / cetyl / stearyl / behenyl) dimer dilinoleate, dimer dilinoleyl diisostearate, dimer dilinoleyl hydrogenated rosin condensate, dimer dilinoleic acid hydrogenated castor oil, and hydroxyalkyl dimer dilinoleyl ether;Fatty acid alkanolamides such as coconut oil fatty acid monoethanolamide (cocamide MEA), coconut oil fatty acid diethanolamide (cocamide DEA), lauric acid monoethanolamide (lauramide MEA), lauric acid diethanolamide (lauramide DEA), lauric acid monoisopropanolamide (lauramide MIPA), palmitic acid monoethanolamide (palmitamide MEA), palmitic acid diethanolamide (palmitamide DEA), and coconut oil fatty acid methylethanolamide (cocamide methyl MEA); dimethicone (dimethylpolysiloxane), highly polymerized dimethicone (highly polymerized dimethylpolysiloxane), cyclomethicone (cyclic dimethylsiloxane, decamethylcyclopentasiloxane (also simply cyclopentasiloxane)), phenyl trimethicone, diphenyl dimethicone, phenyl dimethicone, stearoxypropyl dimethylamine, (aminoethylaminopropylmethicone / dimethicone). Preferred examples of the silicone oil include silicones such as methyl methicone copolymer, dimethiconol, dimethiconol crosspolymer, silicone resin, silicone rubber, amino-modified silicones such as aminopropyl dimethicone and amodimethicone, cation-modified silicone, polyether-modified silicones such as dimethicone copolyol, polyglycerin-modified silicone, sugar-modified silicone, carboxylic acid-modified silicone, phosphate-modified silicone, sulfate-modified silicone, alkyl-modified silicone, fatty acid-modified silicone, alkyl ether-modified silicone, amino acid-modified silicone, peptide-modified silicone, fluorine-modified silicone, cation-modified and polyether-modified silicone, amino-modified and polyether-modified silicone, alkyl-modified and polyether-modified silicone, and polysiloxane-oxyalkylene copolymer; and fluorine-based oils such as perfluorodecane, perfluorooctane, and perfluoropolyether.
[0036] Examples of moisturizing agents and texture improvers include polyols and polymers thereof such as glycerin, trimethylolpropane, pentaerythritol, hexylene glycol, diglycerin, polyglycerin, diethylene glycol, dipropylene glycol, polypropylene glycol, and ethylene glycol-propylene glycol copolymers; glycol alkyl ethers such as diethylene glycol monoethyl ether (ethoxydiglycol), ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, and diethylene glycol dibutyl ether; water-soluble esters such as (eicosanedioic acid / tetradecanedioic acid) polyglyceryl-10 and tetradecanedioic acid polyglyceryl-10; sugar alcohols such as sorbitol, xylitol, erythritol, mannitol, and maltitol; glucose, fructose, galactose, mannose, threose, xylose, arabinose, fucose, ribose, deoxyribose, maltose, trehalose, lactose, raffinose, gluconic acid, glucuronic acid, cyclodextrins (α-, β-, γ-cyclodextrin, and maltose), Modified cyclodextrins (e.g., cyclodextrins modified by silylating or hydroxyalkylating), β-glucan, chitin, chitosan, heparin and its derivatives, pectin, arabinogalactan, dextrin, dextran, glycogen, ethyl glucoside, glucosyl ethyl methacrylate polymers or copolymers, and other sugars and derivatives thereof; hyaluronic acid, sodium hyaluronate; sodium chondroitin sulfate; mucoitin sulfate, caronin sulfate, keratosulfate, dermatan sulfate; Tremella fuciformis extract, Tremella fuciformis polysaccharide; fucoidan; tuberose polysaccharide, or naturally derived Polysaccharides; organic acids such as citric acid, tartaric acid, and lactic acid and their salts; urea and its derivatives; 2-pyrrolidone-5-carboxylic acid and its sodium salts, etc.; amino acids such as betaine (trimethylglycine), proline, hydroxyproline, arginine, lysine, serine, glycine, alanine, phenylalanine, tyrosine, β-alanine, threonine, glutamic acid, glutamine, glucocyamine, asparagine, aspartic acid, cysteine, cystine, methionine, leucine, isoleucine, valine, tryptophan, histidine, and taurine and their salts;Collagen, fish collagen, atelocollagen, gelatin, elastin, collagen hydrolysis peptides, hydrolyzed collagen, hydroxypropylammonium chloride hydrolyzed collagen, elastin hydrolysis peptides, keratin hydrolysis peptides, hydrolyzed keratin, conchiolin hydrolysis peptides, hydrolyzed conchiolin, silk proteolysis peptides, hydrolyzed silk, sodium lauroyl hydrolyzed silk, soybean proteolysis peptides, wheat proteolysis peptides, hydrolyzed wheat protein, casein hydrolysis peptides, acylated peptides and their derivatives; acylated peptides such as palmitoyl oligopeptide, palmitoyl pentapeptide, palmitoyl tetrapeptide; Preferred examples of such ingredients include silylated peptides; lactic acid bacteria culture medium, yeast extract, eggshell membrane protein, bovine submandibular gland mucin, hypotaurine, sesame lignan glycoside, glutathione, albumin, whey; choline chloride, phosphorylcholine; animal and plant extracts such as placenta extract, alastin, collagen, aloe extract, witch hazel water, loofah water, chamomilla extract, licorice extract, comfrey extract, silk extract, Rosa robur extract, yarrow extract, eucalyptus extract, and melilot extract; and ceramides such as natural ceramides (types 1, 2, 3, 4, 5, and 6), hydroxyceramides, pseudoceramides, glycosphingolipids, ceramides, and glycoceramide-containing extracts.
[0037] Preferred surfactants include anionic surfactants, nonionic surfactants, cationic surfactants, amphoteric surfactants, polymer surfactants, etc. Preferred examples of the surfactant include anionic surfactants such as fatty acid salts such as potassium laurate and potassium myristate; alkyl sulfate ester salts such as sodium lauryl sulfate, triethanolamine lauryl sulfate, and ammonium lauryl sulfate; polyoxyethylene alkyl sulfates such as sodium laureth sulfate and triethanolamine laureth sulfate; acyl N-methylamino acid salts such as sodium cocoyl methyl taurate, potassium cocoyl methyl taurate, sodium lauroyl methyl taurate, sodium myristoyl methyl taurate, sodium lauroyl methyl alanine, sodium lauroyl sarcosine, triethanolamine lauroyl sarcosine, and sodium lauroyl methyl alanine glutamate; sodium cocoyl glutamate, triethanolamine cocoyl glutamate, sodium lauroyl glutamate, sodium myristoyl glutamate, sodium stearoyl glutamate, ditriethanolamine palmitoyl aspartate, triethanolamine cocoyl alanine glutamate, sodium methyl ... ethanolamine and the like; polyoxyethylene alkyl ether acetates such as sodium laureth acetate; succinate ester salts such as sodium lauroyl monoethanolamide succinate; fatty acid alkanolamide ether carboxylates; acyl lactate salts; polyoxyethylene fatty amine sulfates; fatty acid alkanolamide sulfates; fatty acid glyceride sulfates such as sodium hydrogenated coconut oil fatty acid glycerin sulfate; alkylbenzene polyoxyethylene sulfates; olefin sulfonates such as sodium α-olefin sulfonate; alkyl sulfosuccinates such as disodium lauryl sulfosuccinate and dioctyl sodium sulfosuccinate; alkyl ether sulfosuccinates such as disodium laureth sulfosuccinate, sodium monolauroyl monoethanolamide polyoxyethylene sulfosuccinate, and sodium lauryl polypropylene glycol sulfosuccinate; alkyl benzene sulfonates such as sodium tetradecylbenzene sulfonate and triethanolamine tetradecylbenzenesulfonate;alkyl naphthalene sulfonates; alkanesulfonates; α-sulfofatty acid methyl ester salts; acyl isethionates; alkyl glycidyl ether sulfonates; alkyl sulfoacetates; alkyl ether phosphate salts such as sodium laureth phosphate, sodium dilaureth phosphate, sodium trilaureth phosphate, and sodium monoolethphosphate; alkyl phosphate salts such as potassium lauryl phosphate; sodium caseinate; alkylaryl ether phosphate salts; fatty acid amide ether phosphate salts; phospholipids such as phosphatidylglycerol, phosphatidylinositol, and phosphatidic acid; silicone-based anionic surfactants such as carboxylic acid-modified silicone, phosphate-modified silicone, and sulfate-modified silicone; and nonionic surfactants such as laureths (polyoxyethylene lauryl ethers), ceteths (polyoxyethylene cetyl ethers), steareths (polyoxyethylene stearyl ethers), beheneths (polyoxyethylene behenyl ethers), isosteareths (polyoxyethylene isostearyl ethers), octyldodeceths (polyoxyethylene octyl dodecyl ethers); polyoxyethylene alkylphenyl ethers; castor oil and hydrogenated castor oil derivatives such as polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil monoisostearate, polyoxyethylene hydrogenated castor oil triisostearate, polyoxyethylene hydrogenated castor oil monopyroglutamic acid monoisostearate diester, and polyoxyethylene hydrogenated castor oil maleic acid; polyoxyethylene phytosterols; polyoxyethylene cholesterol; polyoxyethylene cholestanol; polyoxyethylene lanolin; polyoxyethylene reduced lanolin; polyoxyethylene-polyoxypropylene cetyl ether, polyoxyethylene-polyoxypropylene 2-decyltetradecyl ether, polyoxyethylene-polyoxypropylene monobutyl ether, polyoxyethylene-polyoxypropylene hydrogenated lanolin, and polyoxyethylene-polyoxypropylene alkyl ethers such as polyoxyethylene-polyoxypropylene glycerin ether;Polyoxyethylene polyoxypropylene glycol; (poly)glycerin polyoxypropylene glycol such as PPG-9 diglyceryl; glycerin fatty acid partial esters such as glyceryl stearate, glyceryl isostearate, glyceryl palmitate, glyceryl myristate, glyceryl oleate, glyceryl coconut oil fatty acid, glycerin monocottonseed oil fatty acid, glycerin monoerucate, glycerin sesquioleate, α,α'-oleic acid pyroglutamic acid glycerin, and glycerin monostearate malic acid; polyglycerin stearate Lyceryl-2, 3, 4, 5, 6, 8, 10, Polyglyceryl-6 distearate, 10, Polyglyceryl-2 tristearate, Polyglyceryl-10 deca-stearate, Polyglyceryl-2 isostearate, 3, 4, 5, 6, 8, 10, Polyglyceryl-2 diisostearate (diglyceryl diisostearate), 3, 10, Polyglyceryl-2 triisostearate, Polyglyceryl-2 tetraisostearate, Polyglyceryl-10 deca-isostearate, Polyglyceryl-2 oleate, 3, 4 , 5, 6, 8, 10, polyglycerin fatty acid esters such as polyglyceryl-6 dioleate, polyglyceryl-2 trioleate, and polyglyceryl-10 decaoleate; ethylene glycol mono fatty acid esters such as ethylene glycol monostearate; propylene glycol mono fatty acid esters such as propylene glycol monostearate; pentaerythritol partial fatty acid esters; sorbitol partial fatty acid esters; maltitol partial fatty acid esters; maltitol ether; sorbitan monooleate, sorbitan monoisostearate, and the like. Sorbitan fatty acid esters such as sorbitan stearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan sesquioleate, sorbitan trioleate, diglycerol sorbitan penta-2-ethylhexylate, and diglycerol sorbitan tetra-2-ethylhexylate; partial esters of sugar derivatives such as sucrose fatty acid esters, methyl glucoside fatty acid esters, and trehalose undecylenate; alkyl glucosides such as caprylyl glucoside; alkyl polyglycosides; lanolin alcohol; reduced lanolin;Polyoxyethylene fatty acid mono- and diesters such as polyoxyethylene distearate, polyethylene glycol diisostearate, polyoxyethylene monooleate, and polyoxyethylene dioleate; polyoxyethylene propylene glycol fatty acid esters; polyoxyethylene glycerin fatty acid esters such as polyoxyethylene monooleates such as polyoxyethylene glycerin monostearate, polyoxyethylene glycerin monoisostearate, and polyoxyethylene glycerin triisostearate; polyoxyethylene sorbitan fatty acid esters such as polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monooleate, and polyoxyethylene sorbitan tetraoleate; polyoxyethylene sorbitol fatty acid esters such as polyoxyethylene sorbitol monolaurate, polyoxyethylene sorbitol monooleate, polyoxyethylene sorbitol pentaoleate, and polyoxyethylene sorbitol monostearate; polyoxyethylene methyl Glucoside fatty acid esters; polyoxyethylene alkyl ether fatty acid esters; polyoxyethylene animal and vegetable oils such as polyoxyethylene sorbitol beeswax; alkyl glyceryl ethers such as isostearyl glyceryl ether, chimyl alcohol, selachyl alcohol, and batyl alcohol; polyhydric alcohol alkyl ethers; polyoxyethylene alkylamines; tetrapolyoxyethylene / tetrapolyoxypropylene-ethylenediamine condensates; natural surfactants such as saponin and sophorolipid; polyoxyethylene fatty acid amides; fatty acid alkanolamides such as coconut oil fatty acid monoethanolamide (cocamide MEA), coconut oil fatty acid diethanolamide (cocamide DEA), lauric acid monoethanolamide (lauramide MEA), lauric acid diethanolamide (lauramide DEA), lauric acid monoisopropanolamide (lauramide MIPA), palmitic acid monoethanolamide (palmitamide MEA), palmitic acid diethanolamide (palmitamide DEA), and coconut oil fatty acid methylethanolamide (cocamide methyl MEA);Alkyldimethylamine oxides such as lauramine oxide, cocamine oxide, stearamine oxide, and behenamine oxide; alkylethoxydimethylamine oxide; polyoxyethylene alkyl mercaptan; silicone-based nonionic surfactants such as polyether-modified silicones such as dimethicone copolyol, polysiloxane-oxyalkylene copolymers, polyglycerin-modified silicones, and sugar-modified silicones; cationic surfactants such as behentrimonium chloride, steartrimonium chloride, cetrimonium chloride, and lauryltrimonium chloride; alkyltrimethylammonium chlorides such as limonium chloride; alkyltrimethylammonium bromides such as stearyltrimonium bromide; dialkyldimethylammonium chlorides such as distearyldimonium chloride and dicocodimonium chloride; fatty acid amidoamines and salts thereof such as stearamidopropyldimethylamine and stearamidoethyldiethylamine; alkyl ether amines and salts or quaternary salts thereof such as stearoxypropyldimethylamine; ethyl sulfate long-chain branched fatty acid (12-31) aminopropylethyldimethylammonium, Fatty acid amide type quaternary ammonium salts such as lanolin ethyl sulfate fatty acid aminopropylethyldimethylammonium; polyoxyethylene alkylamines and their salts or quaternary salts; alkylamine salts; fatty acid amide guanidium salts; alkyl ether amine ammonium salts; alkyl trialkylene glycol ammonium salts; benzalkonium salts; benzethonium salts; pyridinium salts such as cetylpyridinium chloride; imidazolinium salts; alkylisoquinolinium salts; dialkylmorphonium salts; polyamine fatty acid derivatives; aminopropyl dimethicone and amodimethicone silicone-based cationic surfactants such as amino-modified silicones, cation-modified silicones, cation-modified and polyether-modified silicones, and amino-modified and polyether-modified silicones; amphoteric surfactants include N-alkyl-N,N-dimethyl amino acid betaines such as lauryl betaine (lauryl dimethyl amino acetate betaine); fatty acid amidoalkyl-N,N-dimethyl amino acid betaines such as cocamidopropyl betaine and lauramidopropyl betaine; imidazoline betaines such as sodium cocoamphoacetate and sodium lauroamphoacetate;Alkyl sulfobetaines such as alkyldimethyltaurine; sulfate-type betaines such as alkyldimethylaminoethanol sulfate esters; phosphate-type betaines such as alkyldimethylaminoethanol phosphate esters; sphingophospholipids such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin, phospholipids such as lysolecithin, hydrogenated soybean phospholipid, partially hydrogenated soybean phospholipid, hydrogenated egg yolk phospholipid, partially hydrogenated egg yolk phospholipid, and hydroxide lecithin; silicone-based amphoteric surfactants; and preferred polymer surfactants include polyvinyl alcohol, sodium alginate, starch derivatives, tragacanth gum, and acrylic acid / alkyl methacrylate copolymers; and various silicone-based surfactants.
[0038] Examples of polymers, thickeners, and gelling agents include guar gum, locust bean gum, queen seed, carrageenan, galactan, gum arabic, tara gum, tamarind, furcellaran, karaya gum, aoi, caragam, tragacanth gum, pectin, pectinic acid and its sodium salt and other salts, alginic acid and its sodium salt and other salts, mannan; starches such as rice, corn, potato, and wheat; xanthan gum, dextran, succinoglucan, curdlan, hyaluronic acid and its salts, xanthan gum, pullulan, gellan gum, and chitin. cellulose, chitosan, agar, cassou extract, chondroitin sulfate, casein, collagen, gelatin, albumin; cellulose and its derivatives such as methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, carboxymethyl cellulose and its salts such as sodium salt, methylhydroxypropyl cellulose, sodium cellulose sulfate, dialkyldimethylammonium cellulose sulfate, crystalline cellulose, cellulose powder; soluble starch, carboxymethyl starch, Starch-based polymers such as methylhydroxypropyl starch, methyl starch, and the like, starch derivatives such as hydroxypropyltrimonium starch chloride, corn starch aluminum octenylsuccinate, and the like; alginic acid derivatives such as sodium alginate, propylene glycol alginate, and the like; polyvinylpyrrolidone (PVP), polyvinyl alcohol (PVA), vinylpyrrolidone-vinyl alcohol copolymer, polyvinyl methyl ether; polyethylene glycol, polypropylene glycol, polyoxyethylene-polyoxypropylene copolymer; amphoteric methacrylate ester copolymers such as (methacryloyloxyethyl carboxybetaine / alkyl methacrylate) copolymer, (acrylates / stearyl acrylate / ethylamine oxide methacrylate) copolymer; (dimethicone / vinyl dimethicone) crosspolymer, (alkyl acrylate / diacetone acrylamide) copolymer, (alkyl acrylate / diacetone acrylamide) copolymer AMP; partially saponified polyvinyl acetate, maleic acid copolymer; vinylpyrrolidone-dialkylaminoalkyl methacrylate copolymer;Acrylic resin alkanolamine; polyester, water-dispersible polyester; polyacrylamide; polyacrylic acid ester copolymers such as polyethyl acrylate, carboxyvinyl polymers, polyacrylic acid and its salts such as sodium salt, acrylic acid-methacrylic acid ester copolymers; acrylic acid-alkyl methacrylate copolymers; cationized cellulose such as Polyquaternium-10, diallyldimethylammonium chloride-acrylamide copolymers such as Polyquaternium-7, acrylic acid-diallyldimethylammonium chloride copolymers such as Polyquaternium-22, acrylic acid-diallyldimethylammonium chloride-acrylamide copolymers such as Polyquaternium-39, acrylic acid-cationized methacrylic acid ester copolymers, acrylic acid-cationized methacrylic acid amide copolymers, acrylic acid-methyl acrylate-methacrylamide propyl chloride such as Polyquaternium-47 trimethylammonium copolymer, methacrylic acid chloride choline ester polymer; cationic polysaccharides such as cationic oligosaccharides, cationized dextran, and guar hydroxypropyltrimonium chloride; polyethyleneimine; cationic polymers; 2-methacryloyloxyethyl phosphorylcholine polymers such as polyquaternium-51 and copolymers with butyl methacrylate copolymers, etc.; polymer emulsions such as acrylic resin emulsions, polyethyl acrylate emulsions, polyacrylic alkyl ester emulsions, polyvinyl acetate resin emulsions, natural rubber latex, and synthetic latex; nitrocellulose; polyurethanes and various copolymers; various silicones; various silicone-based copolymers such as acrylic-silicone graft copolymers; various fluorine-based polymers; 12-hydroxystearic acid and its salts; dextrin fatty acid esters such as dextrin palmitate and dextrin myristate;Preferred examples include anhydrous silicic acid, fumed silica (ultrafine particle anhydrous silicic acid), aluminum magnesium silicate, sodium magnesium silicate, metal soap, dialkyl phosphate metal salt, bentonite, hectorite, organically modified clay mineral, sucrose fatty acid ester, and fructooligosaccharide fatty acid ester. Among these examples, cellulose and its derivatives, alginic acid and its salts, polyvinyl alcohol, hyaluronic acid and its salts, and collagen are preferred.
[0039] Preferred examples of the solvent include lower alcohols such as ethanol, 2-propanol (isopropyl alcohol), butanol, and isobutyl alcohol; glycols such as propylene glycol, diethylene glycol, dipropylene glycol, and isopentyl diol; glycol ethers such as diethylene glycol monoethyl ether (ethoxydiglycol), ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, triethylene glycol monoethyl ether, diethylene glycol diethyl ether, diethylene glycol dibutyl ether, propylene glycol monoethyl ether, and dipropylene glycol monoethyl ether; glycol ether esters such as ethylene glycol monoethyl ether acetate, diethylene glycol monoethyl ether acetate, and propylene glycol monoethyl ether acetate; glycol esters such as diethoxyethyl succinate and ethylene glycol disuccinate; benzyl alcohol, benzyloxyethanol, propylene carbonate, dialkyl carbonate, acetone, ethyl acetate, N-methylpyrrolidone; and toluene.
[0040] Preferred examples of the antioxidant include tocopherol (vitamin E), tocopherol derivatives such as tocopherol acetate; BHT, BHA; gallic acid derivatives such as propyl gallate; vitamin C (ascorbic acid) and / or derivatives thereof; erythorbic acid and derivatives thereof; sulfites such as sodium sulfite; bisulfites such as sodium bisulfite; thiosulfates such as sodium thiosulfate; metabisulfites; thiotaurine, hypotaurine; thioglycerol, thiourea, thioglycolic acid, and cysteine hydrochloride.
[0041] Preferred reducing agents include thioglycolic acid, cysteine, cysteamine, and the like.
[0042] Preferred examples of the oxidizing agent include hydrogen peroxide, ammonium persulfate, sodium bromate, and percarbonate.
[0043] Preferred examples of the preservative, antibacterial agent, and disinfectant include hydroxybenzoic acids such as methylparaben, ethylparaben, propylparaben, and butylparaben, and salts or esters thereof; salicylic acid; sodium benzoate; phenoxyethanol; isothiazolinone derivatives such as methylchloroisothiazolinone and methylisothiazolinone; imidazolinium urea; dehydroacetic acid and salts thereof; phenols; halogenated bisphenols such as triclosan, acid amides, and quaternary ammonium salts; trichlorocarbanide, zinc pyrithione, benzalkonium chloride, benzethonium chloride, sorbic acid, chlorhexidine, chlorhexidine gluconate, halocarban, hexachlorophene, and hinokitiol; other phenols such as phenol, isopropylphenol, cresol, thymol, parachlorophenol, phenylphenol, and sodium phenylphenol; phenylethyl alcohol, photosensitizers, antibacterial zeolites, and silver ions.
[0044] Preferred examples of the chelating agent include edetates (ethylenediaminetetraacetates) such as EDTA, EDTA 2Na, EDTA 3Na, and EDTA 4Na; hydroxyethylethylenediaminetriacetates such as EDTA 3Na; pentetates (diethylenetriaminepentaacetate); phytic acid; phosphonic acids such as etidronic acid and salts thereof such as sodium salts; polyamino acids such as polyaspartic acid and polyglutamic acid; sodium polyphosphate, sodium metaphosphate, phosphoric acid; sodium citrate, citric acid, alanine, dihydroxyethylglycine, gluconic acid, ascorbic acid, succinic acid, and tartaric acid.
[0045] Preferred examples of the pH adjuster, acid, or alkali include ascorbic acid, citric acid, sodium citrate, lactic acid, sodium lactate, potassium lactate, glycolic acid, succinic acid, acetic acid, sodium acetate, malic acid, tartaric acid, fumaric acid, phosphoric acid, hydrochloric acid, sulfuric acid, monoethanolamine, diethanolamine, triethanolamine, isopropanolamine, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-hydroxymethyl-1,3-propanediol, arginine, sodium hydroxide, potassium hydroxide, aqueous ammonia, guanidine carbonate, and ammonium carbonate.
[0046] Examples of powders include mica, talc, kaolin, sericite, montmorillonite, kaolinite, mica, muscovite, phlogopite, synthetic mica, lepidolite, biotite, vermiculite, magnesium carbonate, calcium carbonate, aluminum silicate, barium silicate, calcium silicate, magnesium silicate, strontium silicate, metal tungstate, magnesium, zeolite, barium sulfate, calcined calcium sulfate, calcium phosphate such as tricalcium phosphate, fluorapatite, hydroxyapatite, ceramic powder, bentonite, smectite, clay, mud, metal soap (e.g., zinc myristate, calcium palmitate, aluminum stearate), calcium carbonate, red iron oxide, yellow iron oxide, black iron oxide, ultramarine, iron blue, carbon black, titanium oxide, fine and ultrafine titanium oxide particles, zinc oxide, fine and ultrafine zinc oxide particles, alumina, silica, fumed silica (ultrafine silicic anhydride particles), mica titanium dioxide, and the like. Preferred examples include inorganic powders of various sizes and shapes, such as tan, fish scale foil, boron nitride, photochromic pigments, synthetic fluorine phlogopite, fine particle composite powders, gold, silver, platinum, and aluminum, and inorganic powders obtained by treating these with silicones such as hydrogen silicone and cyclic hydrogen silicone, or other silanes, or various surface treatment agents such as titanium coupling agents to make them hydrophobic or hydrophilic; organic powders of various sizes and shapes, such as starch, cellulose, nylon powder, polyethylene powder, polymethyl methacrylate powder, polystyrene powder, styrene-acrylic acid copolymer resin powder, polyester powder, benzoguanamine resin powder, polyethylene terephthalate-polymethyl methacrylate laminated powder, polyethylene terephthalate-aluminum-epoxy laminated powder, urethane powder, silicone powder, and Teflon (registered trademark) powder, as well as surface-treated powders and organic-inorganic composite powders.
[0047] Preferred examples of inorganic salts include sodium chloride-containing salts such as table salt, ordinary salt, rock salt, sea salt, and natural salt; potassium chloride, aluminum chloride, calcium chloride, magnesium chloride, bittern, zinc chloride, and ammonium chloride; sodium sulfate, aluminum sulfate, aluminum-potassium sulfate (alum), aluminum-ammonium sulfate, barium sulfate, calcium sulfate, potassium sulfate, magnesium sulfate, zinc sulfate, iron sulfate, and copper sulfate; sodium phosphates such as monosodium, disodium, and trisodium phosphate, potassium phosphates, calcium phosphates, and magnesium phosphates.
[0048] Examples of ultraviolet absorbers include benzoic acid-based ultraviolet absorbers such as para-aminobenzoic acid, para-aminobenzoic acid monoglycerin ester, N,N-dipropoxypara-aminobenzoic acid ethyl ester, N,N-diethoxypara-aminobenzoic acid ethyl ester, N,N-dimethylpara-aminobenzoic acid ethyl ester, N,N-dimethylpara-aminobenzoic acid butyl ester, and N,N-dimethylpara-aminobenzoic acid methyl ester; anthranilic acid-based ultraviolet absorbers such as homomenthyl-N-acetylanthranilate; salicylic acid-based ultraviolet absorbers such as salicylic acid and its sodium salt, amyl salicylate, menthyl salicylate, homomenthyl salicylate, octyl salicylate, phenyl salicylate, benzyl salicylate, and p-isopropanolphenyl salicylate; octyl cinnamate, ethyl ... cinnamic acid-based ultraviolet absorbers such as ethyl-4-isopropyl cinnamate, methyl-2,5-diisopropyl cinnamate, ethyl-2,4-diisopropyl cinnamate, methyl-2,4-diisopropyl cinnamate, propyl-p-methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p-methoxycinnamate, 2-ethylhexyl-p-methoxycinnamate (octyl para-methoxycinnamate), 2-ethoxyethyl-p-methoxycinnamate (cinoxate), cyclohexyl-p-methoxycinnamate, ethyl-α-cyano-β-phenylcinnamate, 2-ethylhexyl-α-cyano-β-phenylcinnamate (octocurine), glyceryl mono-2-ethylhexanoyl-di-para-methoxycinnamate, ferulic acid and its derivatives;Benzophenone-based ultraviolet absorbers such as 2,4-dihydroxybenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone, 2,2',4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone (oxybenzone-3), 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonate, 4-phenylbenzophenone, 2-ethylhexyl-4'-phenyl-benzophenone-2-carboxylate, 2-hydroxy-4-n-octoxybenzophenone, and 4-hydroxy-3-carboxybenzophenone; 3-(4'-methylbenzylidene)-d,l-camphor, 3-benzylidene-d,l-camphor; 2-phenyl-5-methylbenzoxazole; 2,2'-hydroxy-5-methylphenylbenzotriazole; 2-(2'-hydroxy 2-(2'-hydroxy-5'-methylphenylbenzotriazole; dibenzalazine; dianisoylmethane; 5-(3,3-dimethyl-2-norbornylidene)-3-pentan-2-one; dibenzoylmethane derivatives such as 4-t-butylmethoxydibenzoylmethane; octyltriazone; urocanic acid derivatives such as urocanic acid and ethyl urocanate; 2-(2'-hydroxy-5'-methylphenyl Preferred examples include hydantoin derivatives such as 1-(3,4-dimethoxyphenyl)-4,4-dimethyl-1,3-pentanedione, 2-ethylhexyl dimethoxybenzylidene dioxoimidazolidinepropionate, phenylbenzimidazolazole sulfonic acid, terephthalylidene dicamphor sulfonic acid, drometrizole trisiloxane, methyl anthranilate, rutin and its derivatives, and oryzanol and its derivatives;
[0049] Examples of whitening agents include hydroquinone glycosides such as arbutin and α-arbutin and esters thereof; ascorbic acid, ascorbic acid phosphate salts such as sodium ascorbic acid phosphate and magnesium ascorbic acid phosphate, ascorbic acid fatty acid esters such as ascorbic acid tetraisopalmitate, ascorbic acid alkyl ethers such as ascorbic acid ethyl ether, ascorbic acid glucosides and fatty acid esters thereof such as ascorbic acid-2-glucoside, ascorbic acid sulfate, and ascorbic acid derivatives such as tocopheryl ascorbyl phosphate; Preferred examples include diacid, ellagic acid, tranexamic acid and derivatives thereof, ferulic acid and derivatives thereof, placenta extract, glutathione, oryzanol, butylresorcinol, plant extracts such as oil-soluble chamomilla extract, oil-soluble licorice extract, Nishikawa willow extract and saxifrage extract, 4-n-butylresorcinol (Rucinol), linoleic acid S (Linolec S), 4-methoxysalicylic acid potassium salt, adenosine phosphate disodium, 5,5'-dipropyl-biphenyl-2,2'-diol (magnolignan), dexpanthenol W, tranexamic acid cetyl hydrochloride, and rhododenol.
[0050] Vitamins and derivatives thereof include vitamin A such as retinol, retinol acetate, and retinol palmitate; vitamin B such as thiamine hydrochloride, thiamine sulfate, riboflavin, riboflavin acetate, pyridoxine hydrochloride, pyridoxine dioctanoate, pyridoxine dipalmitate, flavin adenine dinucleotide, cyanocobalamin, folic acids, nicotinic acids such as nicotinamide and benzyl nicotinate, and cholines; vitamin C such as ascorbic acid and its sodium salts; vitamin D; vitamin E such as α-, β-, γ-, and δ-tocopherol; other vitamins such as pantothenic acid and biotin; and vitamin B such as ascorbic acid phosphate sodium salt and ascorbic acid phosphate magnesium salt. Preferred examples include ascorbic acid derivatives such as scorbic acid phosphate salts, ascorbic acid fatty acid esters such as ascorbic acid tetraisopalmitate, ascorbyl stearate, ascorbyl palmitate, and ascorbyl dipalmitate, ascorbic acid alkyl ethers such as ascorbic acid ethyl ether, ascorbic acid glucosides and fatty acid esters thereof such as ascorbic acid-2-glucoside, and tocopheryl ascorbyl phosphate; vitamin derivatives such as tocopherol derivatives such as tocopherol nicotinate, tocopherol acetate, tocopherol linoleate, tocopherol ferulate, and tocopherol phosphate; tocotrienol; and various other vitamin derivatives.
[0051] Examples of hair growth agents, blood circulation promoters, and stimulants include plant extracts and tinctures such as Swertia japonica extract, capsicum tincture, ginger tincture, ginger extract, and cantharides tincture; capsaicin, nonylic acid vanillylamide, zingerone, ichthammol, tannic acid, borneol, cyclandelate, cinnarizine, tolazoline, acetylcholine, verapamil, cepharanthine, γ-oryzanol, vitamin E, and derivatives such as tocopherol nicotinate and tocopherol acetate; and γ-oryzanol, nicotinic acid, and nicotinic acid derivatives. Preferred examples of the inhibitor include derivatives of tinamide, nicotinic acid benzyl ester, inositol hexanicotinate, nicotine alcohol, and the like, allantoin, photosensitizer 301, photosensitizer 401, capronium chloride, pentadecanoic acid monoglyceride, flavanonol derivatives, stigmasterol or stigmastanol and glycosides thereof, minoxidil, the ALK5 inhibitory compounds described in the specification of WO 2005 / 085241, and the WNT-5A inhibitory compounds described in the specification of WO 2003 / 086334.
[0052] Preferred examples of the anti-graying agent include watercress, soapberry, saxifrage, and thyme.
[0053] Preferred examples of hormones include estradiol, estrone, ethinylestradiol, cortisone, hydrocortisone, and prednisone.
[0054] Other medicinal agents such as anti-wrinkle agents, anti-aging agents, firming agents, cooling agents, warming agents, wound healing promoters, irritation soothing agents, analgesics, and cell activators include retinols, retinoic acids, and tocopheryl retinoate; lactic acid, glycolic acid, gluconic acid, fruit acid, salicylic acid, and derivatives thereof such as glycosides and esters thereof, hydroxycapric acid, long-chain α-hydroxy fatty acids, and long-chain α-hydroxy fatty acid cholesteryl, and other α- or β-hydroxy acids and derivatives thereof; γ-aminobutyric acid, γ-amino-β-hydroxybutyric acid; carnitine; carnosine; creatine; ceramides, sphingosines; caffeine, xanthine, and derivatives thereof; coenzyme Q10, carotene, lycopene, astaxanthin, lutein, α-lipoic acid, platinum Preferred examples include antioxidants / active oxygen scavengers such as nanocolloids and fullerenes; catechins; flavones such as quercetin; isoflavones; gallic acid and ester sugar derivatives; polyphenols such as tannin, sesamin, protoanthocyanidin, chlorogenic acid, and apple polyphenol; rutin and its derivatives; hesperidin and its derivatives; lignan glycosides; licorice extract-related substances such as glabridin, glabrene, liquiritin, and isoliquiritin; lactoferrin; shogaol, gingerol; fragrance substances and derivatives thereof such as menthol and cedrol; capsaicin, vanillin, and derivatives thereof; insect repellents such as diethyltoluamide; and complexes of physiologically active substances and cyclodextrins.
[0055] Plant, animal and microbial extracts include iris extract, angelica extract, douglas fir extract, asparagus extract, avocado extract, hydrangea extract, almond extract, althaea extract, arnica extract, aloe extract, apricot extract, apricot kernel extract, ginkgo extract, chinko extract, fennel extract, turmeric extract, oolong tea extract, uva-ursi extract, angelica tree extract, echinacea leaf extract, emmeiso extract, scutellaria root extract, phellodendron bark extract, coptis extract, barley extract, ginseng extract, St. John's wort extract, and odo extract. Lycosoma extract, Ononis extract, Watercress extract, Orange extract, Dried seawater, Seaweed extract, Oyster leaf extract, Kakyoku extract, Hydrolyzed elastin, Hydrolyzed wheat powder, Hydrolyzed silk, Pueraria root extract, Chamomilla extract, Oil-soluble Chamomilla extract, Carrot extract, Artemisia capillaris extract, Oat extract, Karkade extract, Licorice extract, Oil-soluble Licorice extract, Kiwi extract, Angelica root extract, Wood ear extract, Cinchona extract, Cucumber extract, Paulownia leaf extract, Guanosine, Guava extract, Sophora root extract, Gardenia extract, Sasa veitchii extract Sophora flavescens extract, walnut extract, chestnut extract, grapefruit extract, clematis extract, black rice extract, brown sugar extract, black vinegar, chlorella extract, mulberry extract, gentian extract, geranium extract, black tea extract, yeast extract, magnolia bark extract, coffee extract, burdock extract, rice extract, fermented rice extract, fermented rice bran extract, rice germ oil, comfrey extract, collagen, cowberry extract, Chinese radish extract, Bupleurum Root extract, umbilical cord extract, saffron extract, salvia extract, soapwort extract, bamboo grass extract, hawthorn extract, Chinese radish extract , Zanthoxylum extract, Shiitake mushroom extract, Rehmannia root extract, Lithospermum root extract, Perilla extract, Tilia extract, Meadowsweet extract, Jatoba extract, Peony extract, Angelica root extract, Calamus root extract, Birch extract, White wood ear extract, Horsetail extract, Stevia extract, Stevia fermented product, Nishikawa willow extract, Ivy extract, Hawthorn extract, Elderberry extract, Yarrow extract, Peppermint extract, Sage extract, Mallow extract, Cnidium extract, Swertia japonica extract, Sophora japonica extract, Rhubarb extract,Soybean extract, Chinese laurel extract, thyme extract, dandelion extract, lichen extract, tea extract, clove extract, Imperata cylindrica extract, tangerine extract, tea tree oil, sweet tea extract, chili pepper extract, angelica extract, calendula extract, peach kernel extract, spruce extract, Houttuynia cordata extract, tomato extract, natto extract, carrot extract, garlic extract, wild rose extract, hibiscus extract, burdock extract, lotus extract, parsley extract, birch extract, honey, witch hazel extract, parietaria extract, jasmine extract, bisabolol, cypress extract, bifidobacteria extract, loquat extract, coltsfoot extract, butterbur extract, poria cocos extract, butcher's broom extract, grape extract, grape seed extract Preferred examples of extracts include kiss, propolis, loofah extract, safflower extract, peppermint extract, linden extract, peony extract, hop extract, squid extract, pine extract, horse chestnut extract, skunk cabbage extract, soapberry extract, melissa extract, mozuku extract, peach extract, cornflower extract, eucalyptus extract, saxifrage extract, yuzu extract, lily extract, coix seed extract, mugwort extract, lavender extract, green tea extract, eggshell membrane extract, apple extract, rooibos tea extract, lychee extract, lettuce extract, lemon extract, forsythia extract, astragalus extract, rose extract, rosemary extract, Roman chamomile extract, royal jelly extract, and burnet extract.
[0056] Antipruritic agents include diphenhydramine hydrochloride, chlorpheniramine maleate, camphor, substance P inhibitors, and the like.
[0057] Examples of keratin exfoliating / dissolving agents include salicylic acid, sulfur, resorcinol, selenium sulfide, and pyridoxine.
[0058] Antiperspirants include aluminum chlorohydrate, aluminum chloride, zinc oxide, zinc paraphenolsulfonate, and the like.
[0059] Cooling agents include menthol and methyl salicylate.
[0060] Astringents include citric acid, tartaric acid, lactic acid, aluminum potassium sulfate, tannic acid, and the like.
[0061] Examples of enzymes include superoxide dismutase, catalase, lysozyme chloride, lipase, papain, pancreatin, and protease.
[0062] Preferred examples of nucleic acids include ribonucleic acid and salts thereof, deoxyribonucleic acid and salts thereof, and adenosine triphosphate disodium.
[0063] Fragrances include acetyl cedrene, amyl cinnamaldehyde, allyl amyl glycolate, β-ionone, ISOE Super, isobutylquinoline, iris oil, iron, indole, ylang-ylang oil, undecanal, undecenal, γ-undecalactone, estragole, eugenol, oakmoss, opoponax resinoid, orange oil, eugenol, aurantiol, galacsolid, carvacrol, L-carvone, camphor, cannon, carrot seed oil, clove oil, methyl cinnamate, geraniol, geranyl nitrile, isobornyl acetate, geranyl acetate, dimethylbenzylcarbinyl acetate, styrallyl acetate, cedryl acetate, terpinel acetate, and p-t-butylcyclohexyl acetate. , vetiveryl acetate, benzyl acetate, linalyl acetate, isopentyl salicylate, benzyl salicylate, sandalwood oil, santalol, cyclamen aldehyde, cyclopentadecanolide, methyl dihydrojasmonate, dihydromyrcenol, jasmine absolute, jasmine lactone, cis-jasmone, citral, citronenol, citronellal, cinnamon bark oil, 1,8-cineole, cinnamaldehyde, styrax resinoid, cedarwood oil, cedrene, cedrol, celery seed oil, thyme oil, damascone, damascenone, thymol, tuberose absolute, decanal, decalactone, terpineol, γ-terpinene, tripluran, nerol, nonanal, 2,6-Nonadienol, Nonalactone, Patchouli Alcohol, Vanilla Absolute, Vanillin, Basil Oil, Patchouli Oil, Hydroxycitronellal, α-Pinene, Piperitone, Phenethyl Alcohol, Phenylacetaldehyde, Petitgrain Oil, Hexyl Cinnamaldehyde, cis-3-Hexenol, Balsam of Peru, Vetiver Oil, Vetiverol, Peppermint Oil, Pepper Oil, Heliotropin, Bergamot Oil, Benzyl Benzene Preferred examples of the fragrance include synthetic fragrances, natural fragrances, and various blended fragrances such as maltodextrin, borneol, myrrh resinoid, musk ketone, methylnonylacetaldehyde, γ-methylionone, menthol, L-menthol, L-menthone, eucalyptus oil, β-ionone, lime oil, lavender oil, D-limonene, linalool, lyral, lilial, lemon oil, rose absolute, rose oxide, rose oil, rosemary oil, and various essential oils.
[0064] Pigments, colorants, and dyes include Brown No. 201, Black No. 401, Purple No. 201, Purple No. 401, Blue No. 1, Blue No. 2, Blue No. 201, Blue No. 202, Blue No. 203, Blue No. 204, Blue No. 205, Blue No. 403, Blue No. 404, Green No. 201, Green No. 202, Green No. 204, Green No. 205, Green No. 3, Green No. 401, Green No. 402, and Red No. 1. No. 02, Red 104-1, Red 105-1, Red 106, Red 2, Red 201, Red 202, Red 203, Red 204, Red 205, Red 206, Red 207, Red 208, Red 213, Red 214, Red 215, Red 218, Red 219, Red 220, Red 221, Red 223, Red 225 No., Red No. 226, Red No. 227, Red No. 228, Red No. 230-1, Red No. 230-2, Red No. 231, Red No. 232, Red No. 3, Red No. 401, Red No. 404, Red Color No. 405, Red No. 501, Red No. 502, Red No. 503, Red No. 504, Red No. 505, Red No. 506, Orange No. 201, Orange No. 203, Orange No. 204, Orange No. 205, Legal dyes such as Orange No. 206, Orange No. 207, Orange No. 401, Orange No. 402, Orange No. 403, Yellow No. 201, Yellow No. 202-1, Yellow No. 202-2, Yellow No. 203, Yellow No. 204, Yellow No. 205, Yellow No. 4, Yellow No. 401, Yellow No. 402, Yellow No. 403-1, Yellow No. 404, Yellow No. 405, Yellow No. 406, Yellow No. 407, and Yellow No. 5; Acid Other acid dyes such as Arianor Red 14; basic dyes such as Arianor Sienna Brown, Arianor Madder Red, Arianor Steel Blue, and Arianor Straw Yellow; nitro dyes such as HC Yellow 2, HC Yellow 5, HC Red 3, 4-hydroxypropylamino-3-nitrophenol, N,N'-bis(2-hydroxyethyl)-2-nitro-p-phenylenediamine, HC Blue 2, and Basic Blue 26; disperse dyes;Preferred examples include natural pigments and dyes such as anthraquinones such as astaxanthin and alizarin, naphthoquinones such as anthocyanidin, β-carotene, catenal, capsanthin, chalcone, carthamine, quercetin, crocin, chlorophyll, curcumin, cochineal, and shikonin, bixin, flavones, betacyanidin, henna, hemoglobin, lycopene, riboflavin, and rutin; oxidation dye intermediates and couplers such as p-phenylenediamine, toluene-2,5-diamine, o-, m-, or p-aminophenol, m-phenylenediamine, 5-amino-2-methylphenol, resorcinol, 1-naphthol, 2,6-diaminopyridine, and salts thereof; autoxidation dyes such as indoline; and dihydroxyacetone.
[0065] Preferred examples of the anti-inflammatory agent include glycyrrhizinic acid and derivatives thereof, glycyrrhetinic acid derivatives, salicylic acid derivatives, hinokitiol, guaiazulene, allantoin, indomethacin, ketoprofen, ibuprofen, diclofenac, loxoprofen, celecoxib, infliximab, etanercept, zinc oxide, hydrocortisone acetate, prednisone, diphedramine hydrochloride, chlorpheniramine maleate; and plant extracts such as peach leaf extract and mugwort leaf extract.
[0066] Preferred examples of the anti-asthma, anti-chronic obstructive pulmonary disease, anti-allergic, and immunomodulatory agent include aminophylline, theophyllines, steroids (fluticasone, beclomethasone, etc.), leukotriene antagonists, thromboxane inhibitors, intal, β2 agonists (formoterol, salmeterol, albuterol, tulobuterol, clenbuterol, epinephrine, etc.), tiotropium, ipratropium, dextromethorphan, dimemorfan, bromhexine, tranilast, ketotifen, azelastine, cetirizine, chlorpheniramine, mequitazine, tacrolimus, cyclosporine, sirolimus, methotrexate, cytokine regulators, interferon, omalizumab, and protein / antibody preparations.
[0067] Preferred examples of the anti-infective agent and anti-fungal agent include oseltamivir, zanamivir, and itraconazole. In addition to these, known cosmetic ingredients, pharmaceutical ingredients, food ingredients, etc., such as ingredients listed in the Standards for Cosmetic Raw Materials, Cosmetic Type Ingredient Standards, Japan Cosmetic Industry Association Ingredient Labeling Name List, INCI Dictionary (The International Cosmetic Ingredient Dictionary and Handbook), Quasi-drug Raw Material Standards, Japanese Pharmacopoeia, Pharmaceutical Additive Standards, Food Additives Official Standards, etc., and ingredients listed in Japanese and foreign patent gazettes and patent publications (including published gazettes and republications) classified under the International Patent Classification IPC A61K7 and A61K8, can be contained in known combinations, blending ratios, and blending amounts.
[0068] The composition of the present invention may be in any formulation as long as it can form a film (layer) on the skin or hair surface. Examples of formulations include emulsions such as oil-in-water (O / W), water-in-oil (W / O), W / O / W, and O / W / O, as well as oils, solids, liquids, pastes, sticks, volatile oils, powders, jelly, gels, pastes, emulsified polymers, sheets, mist forms, and sprays, but are not limited to these. The product form may also be any, and the composition may be used as a dispersion, emulsion, cream, pack, spray, gel, or the like. The composition may be formulated with various ingredients known to those skilled in the art to achieve the desired formulation and product form.
[0069] [Method for Producing the Composition] The composition of the present invention can be produced, for example, by mixing and stirring at least one lipid peptide compound, a sucrose ester, water, and optionally other components while heating, followed by allowing to cool to room temperature. The heating and stirring temperature is not particularly limited as long as the components can be mixed uniformly. For example, the stirring temperature can be 50°C to 90°C, 60°C to 90°C, e.g., 70°C or 80°C, and the stirring time can be appropriately selected, for example, between 5 minutes and 3 hours.
[0070] The present invention also relates to a method for preventing contamination of the skin or hair surface, which comprises a film-forming step of forming a film on the skin or hair surface consisting of a composition containing the lipid peptide compound and a sucrose ester. Furthermore, the present invention also relates to a method for preventing adhesion of dust, pollen, particulate matter, mites (including dead mites), gaseous substances, or odorous substances to the skin or hair surface, which comprises a film-forming step of forming a film on the skin or hair surface consisting of a composition containing the lipid peptide compound and a sucrose ester. The compositions used in the method for preventing contamination of the skin or hair surface and the method for preventing adhesion of dust, pollen, particulate matter, mites (including dead mites), gaseous substances, or odorous substances to the skin or hair surface can be those described in detail above.
[0071] A film made of the composition of the present invention exerts an effect of preventing contamination of the skin or hair surface by forming an appropriate roughness (hereinafter also referred to as roughness) on the surface of the skin or hair. Roughness is expressed as the range between the maximum and minimum values of height in the vertical direction relative to the surface of the skin or hair, and can be measured, for example, by atomic force microscopy (AFM).
[0072] The roughness of the film formed from the composition of the present invention is, for example, an average surface roughness of 3 nm to 500 nm, more preferably 10 nm to 300 nm.
[0073] The film made of the composition of the present invention is formed with a fiber structure, and the average diameter of the fibers is preferably 10 nm to 100 nm. The average fiber diameter can be calculated from an image of the film surface, which is created by detecting secondary electrons using a scanning electron microscope.
[0074] The present invention will be described in detail below with reference to examples and test examples, but the present invention is not limited to these examples.
[0075] Synthesis Example 1: Synthesis of Lipid Peptide (N-Palmitoyl-Gly-His) The lipid peptide used as the gelling agent in this example was synthesized using the following method. A 500 mL four-neck flask was charged with 14.2 g (91.6 mmol) of histidine, 30.0 g (91.6 mmol) of N-palmitoyl-Gly-methyl, and 300 g of toluene. 35.3 g (183.2 mmol) of a 28% methanol solution of sodium methoxide (a base) was added, and the mixture was heated to 60°C in an oil bath and stirred for 1 hour. The oil bath was then removed, and the mixture was allowed to cool to 25°C. The solution was reprecipitated with 600 g of acetone and collected by filtration. The resulting solid was dissolved in a mixed solution of 600 g of water and 750 g of methanol. 30.5 ml (183.2 mmol) of 6 N hydrochloric acid was added to neutralize the mixture, resulting in the precipitation of a solid, which was then filtered. Next, the obtained solid was dissolved in a mixed solution of 120 g of tetrahydrofuran and 30 g of water at 60°C, 150 g of ethyl acetate was added, and the mixture was cooled from 60°C to 30°C. Thereafter, the precipitated solid was filtered. The obtained solid was further dissolved in a solvent of 120 g of tetrahydrofuran and 60 g of acetonitrile, heated to 60°C, stirred for 1 hour, cooled, and filtered. The obtained solid was washed with 120 g of water, filtered, and then dried under reduced pressure to obtain 26.9 g (yield 65%) of white crystals of N-palmitoyl-Gly-His free form (hereinafter also simply referred to as Pal-GH).
[0076] Examples 1 to 7, Comparative Example 1: Preparation of Pal-GH Compositions Using Various Sugars Pal-GH obtained in the above Synthesis Examples, various sugar activators, and other ingredients were weighed into a 200 mL beaker (manufactured by HARIO Corporation) to obtain the compositions (mass: g) shown in Table 1. The mixture was heated and stirred at 150 rpm for 20 minutes in a water bath set at approximately 80°C to obtain Pal-GH compositions. The dispersibility of Pal-GH in the composition after heating and stirring at 80°C was visually evaluated, with a rating of ∘ indicating that the Pal-GH powder was uniformly dispersed in the composition (no precipitation or powder clumps were observed) and a rating of × indicating that the Pal-GH was unevenly dispersed (precipitation or powder clumps were observed). The results are also shown in Table 1.
[0077]
[0078] Examples 8 to 14, Comparative Example 2: Preparation of Aqueous Dispersions of Pal-GH Compositions Using the Pal-GH compositions obtained in Examples 1 to 7 above, Pal-GH aqueous dispersions having the compositions shown in Table 2 were prepared in a 200 mL beaker (manufactured by HARIO Corporation). Phases A and B were weighed to obtain the compositions (mass: g) shown in Table 2, and then heated to 70°C or higher in a water bath set at approximately 80°C. Phase A was then poured into phase B while heating and stirring, and the mixture was heated and stirred at 150 rpm for 5 minutes to obtain a Pal-GH aqueous dispersion. The prepared Pal-GH aqueous dispersions were visually evaluated, with a rating of ○ indicating that Pal-GH was uniformly dispersed in water (no precipitation or aggregation had occurred) and × indicating that Pal-GH was non-uniformly dispersed in water (precipitation or aggregation had occurred). The results are also shown in Table 2.
[0079]
[0080] Examples 15 to 21: Preparation of Pal-GH Compositions Combining Sucrose Fatty Acid Esters Pal-GH obtained in the above Synthesis Examples, two types of sucrose fatty acid esters, and other ingredients were weighed into a 200 mL beaker (manufactured by HARIO Corporation) so as to obtain the compositions (mass: g) shown in Table 3, and the mixture was heated and stirred at 150 rpm for 20 minutes in a water bath set at approximately 80°C to obtain Pal-GH compositions. The dispersibility of Pal-GH in the composition after heating and stirring at 80°C was visually evaluated, with a rating of ○ indicating that the Pal-GH powder was uniformly dispersed in the composition (no precipitation or powder clumps were observed) and × indicating that the Pal-GH was unevenly dispersed (precipitation or powder clumps were observed). The results are also shown in Table 3.
[0081]
[0082] Examples 22 to 28: Preparation of Aqueous Dispersions of Pal-GH Compositions Using the Pal-GH compositions obtained in Examples 15 to 21, Pal-GH aqueous dispersions having the compositions shown in Table 4 were prepared in a 200 mL beaker (manufactured by HARIO Corporation). Phases A and B were weighed to give the compositions (mass: g) shown in Table 4, and then heated to 70°C or higher in a water bath set at approximately 80°C. Phase A was then poured into phase B while heating and stirring, and the mixture was heated and stirred at 150 rpm for 5 minutes to obtain a Pal-GH aqueous dispersion. The prepared Pal-GH aqueous dispersions were visually evaluated, with a rating of ○ indicating that Pal-GH was uniformly dispersed in water (no precipitation or aggregation had occurred) and × indicating that Pal-GH was unevenly dispersed in water (precipitation or aggregation had occurred). The results are also shown in Table 4.
[0083]
[0084] Examples 22 to 27 and Comparative Example 3: Inhibition of PM2.5 particle adhesion by aqueous dispersion of Pal-GH composition. 2 The plate was cut into four pieces, and 1.0 mL of each of the solutions of Comparative Example 3 and Examples 22 to 27 was applied thereto, followed by drying in a thermostatic chamber at 32°C for 1 hour. 2 1.5 g of PM2.5 particles (NIES-CRM No. urban airborne dust) were placed on a square scale, and each of the samples prepared above was brought into contact with the PM2.5 particles, pressed down with tweezers 10 times, and then pulled up and shaken for 10 seconds to remove any excess PM2.5 particles. The PM2.5 particles attached to each sample were then observed using a microscope VHX-2000 (manufactured by Keyence Corporation). The results for Examples 24, 27, and Comparative Example 3 are shown in Figure 1. Furthermore, the PM2.5 particles in the observed images of Examples 22 to 27 and Comparative Example 3 were colored by image processing, and the area ratio of the colored area to the entire image was calculated. The results are shown in Figure 2.
[0085] Examples 22 to 27 and Comparative Example 3: Inhibition of Cedar Pollen Adhesion by Pal-GH Composition Aqueous Dispersion. 2The plate was cut into four pieces, and 1.0 mL of each of the solutions of Comparative Example 3 and Examples 22 to 27 was applied thereto, followed by drying in a thermostatic chamber at 32°C for 1 hour. 2 1.5 g of cedar pollen (manufactured by ITEA Corporation) was placed on a square scale, and each of the prepared supplemental plates was contacted with the pollen, pressed down 10 times with tweezers, and then shaken for 10 seconds to remove excess pollen. The pollen attached to each supplemental plate was then quantified using an ITEA cedar pollen allergen (Cryj1) ELISA kit. The results are shown in Figure 3. Also, Figure 4 shows the results of observation of cedar pollen attached in Examples 22, 24, and Comparative Example 3 using a scanning electron microscope (SEM) [Miniscope (registered trademark) TM3000 (manufactured by Hitachi High-Technologies Corporation)].
[0086] Examples 29 to 34, Comparative Example 3: Effect of Enhancing Skin Permeation of Pal-GH Composition A human three-dimensional cultured epidermal model (LabCyte EPI-MODEL12, φ10.5 mm, lot number #LCE12-200706-A, manufactured by Japan Tissue Engineering Co., Ltd.) was placed in a 12-well tissue culture plate (IWAKI, manufactured by Asahi Glass Co., Ltd.), and 1 mL of phosphate-buffered saline (pH 7.4) (PBS) was dispensed into each well to serve as a receiver solution. 500 μL of a 1% nicotinamide (Sigma Aldrich)-containing Pal-GH aqueous dispersion prepared according to Table 5 was added to the donor side. The tissue culture plate was then covered with a lid and allowed to stand in an incubator at 37°C to conduct a skin permeation test. The Pal-GH dispersions of Examples 29 to 34 and Comparative Example 3 were added and allowed to permeate for 3 hours, after which the receiver solution and three-dimensional cultured epidermal model were collected. The collected three-dimensional cultured epidermal model was washed three times with 500 μL of PBS, cut into four equal pieces with a scalpel, and placed in a 1.5 mL microtube (manufactured by Eppendorf). Nicotinamide was then extracted from the three-dimensional cultured epidermal model by adding 750 μL of a 1 / 1 v / v methanol / purified water extraction solution and treating with a vortex mixer (manufactured by Kenis Co., Ltd.) for 1 hour, followed by filtration with a 0.45 μm pore size syringe filter (manufactured by Merck). The nicotinamide concentrations in the resulting filtrate and receiver solution were measured by high-performance liquid chromatography (HPLC, manufactured by Agilent), and the amount of nicotinamide permeated through the skin per unit area was calculated. Each sample was tested three times, and the average value was calculated. From this value, the amount of skin permeated 3 hours after permeation was calculated. The HPLC measurement conditions were as follows: Detector: ultraviolet absorption spectrophotometer (measurement wavelength: 260 nm), Column: stainless steel tube with an inner diameter of 4.6 mm and a length of 25 cm packed with 3 μm octadecylsilylated silica gel for HPLC (ODS-4, GL Sciences Inc.), Column temperature: 40°C, Mobile phase: 0.1% aqueous acetic acid / 5 mM aqueous ICP-ALKS7:methanol = 9:1 (v / v). The results are shown in Figures 5 and 6. Figure 5 shows the amount of nicotinamide extracted from the three-dimensional cultured epidermal model, and Figure 6 shows the amount of nicotinamide detected in the reservoir.
[0087]
[0088] Examples 35 to 38, Comparative Example 1: Preparation of Pal-GH Compositions Containing Sucrose Fatty Acid Esters Pal-GH obtained in Synthesis Example 1 above, various sugar activators, and other ingredients were weighed into a 200 mL beaker (manufactured by HARIO Corporation) to give the compositions (mass: g) shown in Table 6. The mixture was heated and stirred at 150 rpm for 20 minutes in a water bath set at approximately 80°C to obtain Pal-GH compositions. The dispersibility of Pal-GH in the composition after heating and stirring at 80°C was visually evaluated, with a rating of ○ indicating that the Pal-GH powder was uniformly dispersed in the composition (no precipitation or powder clumps were observed) and × indicating that the Pal-GH was unevenly dispersed (precipitation or powder clumps were observed). The results are also shown in Table 6.
[0089]
[0090] Examples 39 to 42, Comparative Example 3: Effect of Enhancing Skin Permeation of Pal-GH Composition A human three-dimensional cultured epidermal model (LabCyte EPI-MODEL12, φ10.5 mm, lot number #LCE12-200817-A, manufactured by Japan Tissue Engineering Co., Ltd.) was placed in a 12-well tissue culture plate (IWAKI, manufactured by Asahi Glass Co., Ltd.), and 1 mL of phosphate-buffered saline (pH 7.4) (PBS) was dispensed into each well to serve as a receiver solution. 500 μL of a 1% nicotinamide (Sigma Aldrich)-containing Pal-GH aqueous dispersion prepared according to Table 7 was added to the donor side, and the tissue culture plate was covered with a lid and allowed to stand in an incubator at 37°C to conduct a skin permeation test. The Pal-GH dispersions of Examples 39 to 42 and Comparative Example 3 were added, and after 3 hours of permeation, the receiver solution and three-dimensional cultured epidermal model were collected. The collected three-dimensional cultured epidermal model was washed three times with 500 μL of PBS, cut into four equal pieces with a scalpel, and placed in a 1.5 mL microtube (Eppendorf). Nicotinamide was then extracted from the three-dimensional cultured epidermal model by adding 750 μL of a 1 / 1 v / v methanol / purified water extraction solution and treating with a vortex mixer (Kenis Co., Ltd.) for 1 hour, followed by filtration with a 0.45 μm pore size syringe filter (Merck). The nicotinamide concentrations in the resulting filtrate and receiver solution were measured by high-performance liquid chromatography (HPLC, Agilent) to calculate the amount of nicotinamide permeated through the skin per unit area. Each sample was tested three times, and the average value was calculated. From this value, the amount of skin permeated 3 hours after permeation was calculated. The HPLC measurement conditions were as follows: Detector: ultraviolet absorption spectrophotometer (measurement wavelength: 260 nm), Column: stainless steel tube with an inner diameter of 4.6 mm and a length of 25 cm packed with 3 μm octadecylsilylated silica gel for HPLC (ODS-4, GL Sciences Inc.), Column temperature: 40°C, Mobile phase: 0.1% aqueous acetic acid / 5 mM aqueous ICP-ALKS7:methanol = 9:1 (v / v). The results are shown in Figures 7 and 8. Figure 7 shows the amount of nicotinamide extracted from the three-dimensional cultured epidermal model, and Figure 8 shows the amount of nicotinamide detected in the reservoir.
[0091]
[0092] [Examples 43, 44, Comparative Examples 4 and 5: Inhibition of Pollen, PM2.5 Particle, and Mite Adhesion to Artificial Leather] <Preparation of Samples> According to Table 8, each raw material was heated to 75°C in a 200 mL beaker (manufactured by HARIO Corporation) and stirred, followed by heating and stirring at 75°C for 10 minutes. After 10 minutes, the mixture was cooled with stirring at room temperature until the temperature reached 40°C. In all of the above steps, stirring was performed at 200 rpm.
[0093]
[0094] <Inhibition of Pollen Adhesion on Artificial Leather> Artificial leather Suprale (manufactured by Idemitsu Technofine Co., Ltd.) was cut into 2 cm x 2 cm pieces, and 1.0 mL each of the solutions from Comparative Example 4, Comparative Example 5, Example 43, and Example 44 was applied. The pieces were then dried in a constant temperature bath at 32°C for 1 hour. 1.5 g of cedar pollen (manufactured by ITEA) was placed in a 10 mL Labolan screw cap vial, and the cap was then closed with each of the Suprale prepared above. The cap was then inverted and brought into contact with the cut piece to allow pollen to adhere. Visual observation of the adhered pollen is shown in Figure 9 , and quantification results for Comparative Example 4, Example 43, and Example 44 using the ITEA cedar pollen allergen (Cryj1) ELISA kit are shown in Figure 10 . Example 43 inhibited pollen adhesion more effectively than Comparative Example 4 and Comparative Example 5, and Example 44 exhibited even greater effectiveness, demonstrating its anti-pollution effect.
[0095] <Inhibition of PM2.5 Particle Adhesion on Artificial Leather> Artificial leather Suprale (manufactured by Idemitsu Technofine Co., Ltd.) was cut into 2 cm x 2 cm pieces, and 1.0 mL of each of the solutions from Comparative Example 4, Comparative Example 5, Example 43, and Example 44 was applied. The pieces were then dried for 1 hour in a thermostatic chamber at 32 °C. 1.5 g of PM2.5 particles (NIES-CRM No. urban airborne dust) was placed on a 4 cm x 4 cm scale. Each of the Suprale prepared above was brought into contact with the PM2.5 particles, pressed with tweezers 10 times, and then shaken for 10 seconds to remove excess PM2.5 particles. The PM2.5 particles adhering to each Suprale were then visually observed, and the results are shown in Figure 11. Furthermore, in Comparative Example 4 and Example 44, the amount of PM2.5 particle adhesion was evaluated by quantifying the metal elements contained in the PM2.5 particles using an ICP-emission spectrometer. The results are shown in Figure 12. Example 43 suppressed adhesion of PM2.5 particles more than Comparative Examples 4 and 5, and Example 44 appeared to have an even greater effect, demonstrating the presence of an anti-pollution effect.
[0096] <Inhibition of Adhesion of PM2.5 Particles to Artificial Leather When Sprayed with Compressed Air> Artificial leather Suprale (manufactured by Idemitsu Technofine Co., Ltd.) was cut into 2 cm x 2 cm pieces, and 1.0 mL of each of the solutions from Comparative Example 4 and Example 44 was applied and dried in a constant temperature bath at 32°C for 1 hour. 5.00 mg of PM2.5 particles (NIES-CRM No. urban airborne dust) were sprayed onto each Suprale using compressed air (Figure 13). The Suprale was then recovered, and silicon in the PM2.5 particles was quantified using an energy dispersive X-ray fluorescence analyzer EDX-8000 (manufactured by Shimadzu Corporation). The results are shown in Figure 14. Example 44 suppressed adhesion of PM2.5 particles compared to Comparative Example 4, demonstrating its anti-pollution effect.
[0097] <Inhibition of PM2.5 Particle Adhesion on Artificial Leather When the Composition is Sprayed and Dried> Artificial leather Suprale (manufactured by Idemitsu Technofine Co., Ltd.) was cut into 2 cm x 2 cm pieces, and the solutions of Comparative Example 5 and Example 44 were sprayed from a spray bottle and dried in a thermostatic chamber at 32°C for 10 minutes. Each solution was sprayed by pressing the spray bottle once. 1.5 g of PM2.5 particles (NIES-CRM No. urban airborne dust) was placed in a 4 cm x 4 cm scale. Each of the Suprale prepared above was contacted with the PM2.5 particles, pressed with tweezers 10 times, and then pulled out and shaken for 10 seconds to remove excess PM2.5 particles. The amount of PM2.5 particle adhesion was evaluated by quantifying the metal elements contained in the PM2.5 particles using an ICP-Atomic Emission Spectrometer. The results are shown in Figure 15. Furthermore, carbon tape was applied to the surface of a support plate onto which the solution of Example 44 had been sprayed, and the film formed on the support plate was peeled off. The results of observing the film using a field emission scanning electron microscope JSM-7400F (manufactured by JEOL Ltd.) are shown in Figure 16. Example 44 suppressed the adhesion of PM2.5 particles compared to Comparative Example 5, demonstrating its anti-pollution effect. It was also confirmed that a fibrous film was formed on the surface of the support plate onto which Example 44 had been sprayed.
[0098] <Inhibition of House Dust Mite Adhesion on Artificial Leather> Artificial leather Suprale (manufactured by Idemitsu Technofine Co., Ltd.) was cut into 2 cm x 2 cm pieces, and the solutions of Comparative Example 5 and Example 44 were sprayed from a spray bottle and dried in a thermostatic chamber at 32°C for 10 minutes. Each solution was sprayed by pressing the spray bottle once. 0.5 g of house dust mites (Biosta Co., Ltd.) was placed in a 10 mL Labolan screw cap vial, and the cap was then placed with each of the Suprale prepared above. The sample was then inverted and brought into contact with the cut surface to allow pollen to adhere. The amount of house dust mite adhesion was then evaluated by quantifying Derf1 attached to the Suprale using an ITEA mite (Derf1) high-sensitivity ELISA kit. The results are shown in Figure 17. It was confirmed that the sample of Example 44 inhibited house dust mite adhesion compared to Comparative Example 5. Figure 18 shows a photograph of house dust mites attached to the Suprale.
[0099] <Measurement of Roughness of Coated Film> The solutions prepared in Comparative Example 5 and Example 44 were coated and dried in a thermostatic chamber at 32°C for 10 minutes. The roughness of the film formed on the silicon wafer surface was measured using an AFM atomic force microscope, Dimension Icon (manufactured by Bruker AXS), and the results are shown in Figure 19. The average roughness of Comparative Example 5 was 0.80 nm, while the average roughness of Example 44 was 72.3 nm. Example 44 showed a larger roughness value than Comparative Example 5, suggesting that adhesion of contaminants can be suppressed.
[0100] Example 45, Comparative Example 6: Skin penetration enhancing effect of Pal-GH composition Preparation of sample According to Table 9 below, each raw material was heated to 75°C in a 200 mL beaker (manufactured by HARIO Corporation) and stirred. After heating and stirring at 75°C for 10 minutes, phases A and B were mixed and heated and stirred for an additional 5 minutes. The mixture was then stirred and cooled at room temperature until the temperature reached 40°C. In all of the above steps, stirring was performed at 200 rpm.
[0101]
[0102] <Skin Permeation Test Using a Three-Dimensional Cultured Skin Model> A human three-dimensional cultured epidermal model (LabCyte EPI-MODEL12, φ10.5 mm, lot number #LCE12-201109-A, manufactured by Japan Tissue Engineering Co., Ltd.) was placed in a 12-well tissue culture plate (IWAKI, manufactured by Asahi Glass Co., Ltd.), and 1 mL of phosphate-buffered saline (pH 7.4) (PBS) was dispensed into each well to serve as a receiver solution. 500 μL of the 0.5% retinol-containing solutions of Comparative Example 6 and Example 45 prepared according to Table 9 was added to the donor side. The tissue culture plate was then covered with a lid and allowed to stand in an incubator at 37°C to conduct a skin permeation test. After 24 hours of permeation, the three-dimensional cultured epidermal model was harvested. The collected three-dimensional cultured epidermal model was washed three times with 500 μL of ethanol, cut into four equal pieces with a scalpel, and placed in a 1.5 mL microtube (manufactured by Eppendorf). Retinol was extracted from the three-dimensional cultured epidermal model by adding 750 μL of a 1 / 1 v / v methanol / purified water extract and processing it in a vortex mixer (manufactured by Kenis Co., Ltd.) for 1 hour, followed by filtration through a 0.45 μm pore size syringe filter (manufactured by Merck). The retinol concentration of the resulting filtrate was measured by high-performance liquid chromatography (HPLC, manufactured by Agilent) to calculate the amount of retinol permeated through the skin per unit area. Each sample was tested three times, and the average value was calculated. From this value, the amount of skin permeated 24 hours after permeation was calculated. The HPLC measurement conditions were as follows: Detector: ultraviolet absorptiometer (measurement wavelength: 325 nm), column: stainless steel tube with an inner diameter of 4.6 mm and a length of 25 cm packed with 3 μm octadecylsilylated silica gel for HPLC (ODS-4, GL Sciences Inc.), column temperature: 40°C, mobile phase: water:methanol=5:95 (v / v). The results are shown in Figure 20. Example 45 was shown to enhance the skin permeation of retinol compared to Comparative Example 6.
[0103] Example 46, Comparative Example 7: Skin penetration enhancing effect of Pal-GH composition Preparation of sample According to Table 10 below, each raw material was heated to 75°C in a 200 mL beaker (manufactured by HARIO Corporation) and stirred. After heating and stirring at 75°C for 10 minutes, phases A and B were mixed and heated and stirred for an additional 5 minutes. The mixture was then stirred and cooled at room temperature until the temperature reached 40°C. In all of the above steps, stirring was performed at 200 rpm.
[0104]
[0105] <Skin Permeation Test Using a Three-Dimensional Cultured Skin Model> A human three-dimensional cultured epidermal model (LabCyte EPI-MODEL12, φ10.5 mm, lot number #LCE12-201109-A, manufactured by Japan Tissue Engineering Co., Ltd.) was placed in a 12-well tissue culture plate (IWAKI, manufactured by Asahi Glass Co., Ltd.), and 1 mL of phosphate-buffered saline (pH 7.4) (PBS) was dispensed into each well to serve as a receiver solution. 500 μL of the 1.0% ascorbic acid glycoside formulation solutions of Comparative Example 7 and Example 46 prepared according to Table 10 was added to the donor side. The tissue culture plate was then covered with a lid and allowed to stand in an incubator at 37°C to conduct a skin permeation test. After 24 hours of permeation, the three-dimensional cultured epidermal model was harvested. The collected three-dimensional cultured epidermal model was washed three times with 500 μL of PBS, cut into four equal parts with a scalpel, and placed in a 1.5 mL microtube (manufactured by Eppendorf). Then, 750 μL of a 1 / 1 v / v methanol / purified water extract was added and treated with a vortex mixer (manufactured by Kenis Co., Ltd.) for 1 hour to extract ascorbic acid glycoside from the three-dimensional cultured epidermal model, followed by filtration with a 0.45 μm pore size syringe filter (manufactured by Merck). The ascorbic acid glycoside concentration of the resulting filtrate was measured by high-performance liquid chromatography (HPLC, manufactured by Agilent) to calculate the amount of ascorbic acid glycoside permeated through the skin per unit area. Each sample was tested three times, and the average value was calculated. From this value, the amount of skin permeated 24 hours after permeation was calculated. The HPLC measurement conditions were as follows. Detector: ultraviolet absorption spectrophotometer (measurement wavelength: 260 nm), column: stainless steel tube with an inner diameter of 4.6 mm and a length of 25 cm packed with 3 μm octadecylsilylated silica gel for HPLC (ODS-4, GL Sciences Inc.), column temperature: 40°C, mobile phase: 0.1% aqueous ammonium acetate solution / ICP-TBA-Br aqueous solution:acetonitrile=4:1 (v / v). The results are shown in Figure 21. Example 46 was shown to promote skin permeation of ascorbic acid glycoside compared to Comparative Example 7.
[0106] [Examples 47, 48, and Comparative Example 8: Inhibition of Gobi Yellow Sand Adhesion to Artificial Leather] <Preparation of Samples> Each raw material was added to a 200 mL beaker (manufactured by HARIO Corporation) in the proportions shown in Table 11 below, and heated and stirred at a liquid temperature of 75°C for 10 minutes to obtain a homogeneous solution. After heating and stirring, the mixture was stirred and cooled at room temperature until the liquid temperature reached 40°C, thereby preparing Example 47 sample (hereinafter also referred to as Formulation Example 47), Example 48 sample (hereinafter also referred to as Formulation Example 48), and Comparative Example 8 sample (hereinafter also referred to as Comparative Formulation 8). In all of the above steps, stirring was performed at 200 rpm.
[0107]
[0108] <Inhibition of Gobi Yellow Sand Adhesion on Artificial Leather> Artificial leather Suprale (Idemitsu Technofine Co., Ltd.) was cut into 4 cm x 4 cm pieces, and 2.0 mL of each of the solutions from Example 47, Example 48, and Comparative Example 8 was applied. The pieces were then dried in a constant temperature bath at 32°C for 1 hour. 1.5 g of Gobi Yellow Sand (NIES-CRM No. 30) was placed in a 10 mL Labolan screw cap vial, and the cap was then placed with each of the Suprale caps prepared above. The cap was then inverted and brought into contact with the Gobi Yellow Sand to allow adhesion. Images of the results are shown in Figure 22. The metal elements contained in the Gobi Yellow Sand were then quantified using an ICP-Atomic Emission Spectrometer to evaluate the amount of Gobi Yellow Sand adhesion. The results are shown in Figure 23. Example 47 inhibited Gobi Yellow Sand adhesion compared to Comparative Example 8, and Example 48 demonstrated even greater effectiveness, demonstrating its anti-pollution properties.
[0109] Examples 49 to 52, Comparative Example 9: Effect of Enhancing Skin Permeation of Pal-GH Composition A human three-dimensional cultured epidermal model (LabCyte EPI-MODEL12, φ10.5 mm, lot number #LCE12-210920-A, manufactured by Japan Tissue Engineering Co., Ltd.) was placed in a 12-well tissue culture plate (IWAKI, manufactured by Asahi Glass Co., Ltd.), and 1 mL of phosphate-buffered saline (pH 7.4) (PBS) was dispensed into each well to serve as a receiver solution. 500 μL of an aqueous dispersion containing 1% nicotinamide (manufactured by Sigma Aldrich) prepared according to Table 12 was added to the donor side, and the tissue culture plate was covered with a lid and allowed to stand in an incubator at 37°C to conduct a skin permeation test. The dispersions of Examples 49 to 52 and Comparative Example 9 were added, and after 4 hours of permeation, the receiver solution and three-dimensional cultured epidermal model were collected. The collected three-dimensional cultured epidermal model was washed three times with 500 μL of PBS, cut into four equal parts with a scalpel, and placed in a 1.5 mL microtube (manufactured by Eppendorf). Nicotinamide was then extracted from the three-dimensional cultured epidermal model by adding 750 μL of a 1 / 1 v / v methanol / purified water extraction solution and treating with a vortex mixer (manufactured by Kenis Co., Ltd.) for 1 hour, followed by filtration with a 0.45 μm pore size syringe filter (manufactured by Merck). The nicotinamide concentrations in the resulting filtrate and receiver solution were measured by high-performance liquid chromatography (HPLC, manufactured by Agilent), and the amount of nicotinamide permeated through the skin per unit area was calculated. Each sample was tested three times, and the average value was calculated. From this value, the amount of skin permeated after 4 hours of permeation was calculated. The HPLC measurement conditions were as follows: Detector: ultraviolet absorption spectrophotometer (measurement wavelength: 260 nm), Column: stainless steel tube with an inner diameter of 4.6 mm and a length of 25 cm packed with 3 μm octadecylsilylated silica gel for HPLC (ODS-4, GL Sciences Inc.), Column temperature: 40°C, Mobile phase: 0.1% aqueous acetic acid / 5 mM aqueous ICP-ALKS7 solution:methanol = 9:1 (v / v). The results are shown in Figure 24. Figure 24 shows the amount of nicotinamide detected in the reservoir of the three-dimensional cultured epidermal model.A higher amount of nicotinamide permeated from the cultured skin to which Examples 49 to 52 were added was confirmed compared to the cultured skin to which Comparative Example 9 was added.
[0110]
[0111] Example 53, Comparative Example 10: Effect of Enhancing Skin Permeation of Pal-GH Serum A human three-dimensional cultured epidermal model (LabCyte EPI-MODEL12, φ10.5 mm, lot number #LCE12-210920-A, manufactured by Japan Tissue Engineering Co., Ltd.) was placed in a 12-well tissue culture plate (IWAKI, manufactured by Asahi Glass Co., Ltd.), and 1 mL of phosphate-buffered saline (pH 7.4) (PBS) was dispensed into each well to serve as a receiver solution. 500 μL of a 1% nicotinamide (Sigma Aldrich)-containing serum prepared according to Table 13 was added to the donor side, and the tissue culture plate was covered with a lid and allowed to stand in an incubator at 37°C to conduct a skin permeation test. The serums of Example 53 and Comparative Example 10 were added and allowed to permeate for 4 hours, after which the receiver solution and three-dimensional cultured epidermal model were collected. The collected three-dimensional cultured epidermal model was washed three times with 500 μL of PBS, cut into four equal parts with a scalpel, and placed in a 1.5 mL microtube (manufactured by Eppendorf). Nicotinamide was extracted from the three-dimensional cultured epidermal model by adding 750 μL of a 1 / 1 v / v methanol / purified water extract and processing it in a vortex mixer (manufactured by Kenis Co., Ltd.) for 1 hour, and then filtered through a 0.45 μm pore size syringe filter (manufactured by Merck). The nicotinamide concentrations in the resulting filtrate and receiver solution were measured by high-performance liquid chromatography (HPLC, manufactured by Agilent) to calculate the amount of nicotinamide permeated through the skin per unit area. Each sample was tested three times, and the average value was calculated. From this value, the amount of skin permeated after 4 hours of permeation was calculated. The HPLC measurement conditions were as follows: Detector: ultraviolet absorption spectrophotometer (measurement wavelength: 260 nm), column: stainless steel tube with an inner diameter of 4.6 mm and a length of 25 cm packed with 3 μm octadecylsilylated silica gel for HPLC (ODS-4, GL Sciences Inc.), column temperature: 40°C, mobile phase: 0.1% aqueous acetic acid / 5 mM aqueous ICP-ALKS7 solution:methanol=9:1 (v / v). The results are shown in Figure 25. Figure 25 shows the amount of nicotinamide detected in the reservoir of the three-dimensional cultured epidermal model.A higher amount of nicotinamide permeated from the cultured skin to which the serum of Example 53 was added was confirmed compared to the cultured skin to which the serum of Comparative Example 10 was added.
[0112]
[0113] Example 54, Comparative Example 11: PM2.5 Particle Adhesion Inhibitory Effect of Pal-GH Composition. Artificial leather Suprale (manufactured by Idemitsu Technofine Co., Ltd.) was cut into 2 cm x 2 cm pieces, and 1.0 mL of each of the solutions prepared in Table 14 from Comparative Example 11 and Example 54 was applied. The pieces were then dried in a constant temperature bath at 32 °C for 1 hour. 1.5 g of PM2.5 particles (NIES-CRM No. urban airborne dust) were placed in a 10 mL Labolan screw cap vial, and the cap was then placed with each of the Suprale prepared above. The cap was then inverted and brought into contact with the surface to allow the PM2.5 particles to adhere. Visual observation of the adhered PM2.5 particles is shown in Figure 26. It was confirmed that adhesion of PM2.5 particles was inhibited on the Suprale coated with the solution of Example 54 compared to the Suprale coated with the solution of Comparative Example 11.
[0114]
Claims
1. A composition comprising a lipid peptide type compound in which a lipid portion consisting of an aliphatic group having 10 to 24 carbon atoms is bound to a peptide portion formed by repeating at least two or more identical or different amino acids, and a sucrose ester.
2. The composition according to claim 1 , capable of forming a film on the surface of the skin or hair.
3. The composition according to claim 1 or 2, which prevents adhesion of dust, pollen, particulate matter, mites (including dead mites), gaseous substances, or odorous substances to the surface of skin or hair.
4. The composition according to any one of claims 1 to 3, characterized in that the lipid peptide type compound is at least one of the compounds represented by the following formulas (1) to (3) or pharma- ceutically usable salts thereof. [Formula 1] (In the formula, R 1 represents an aliphatic group having 9 to 23 carbon atoms; R 2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, which may have a branched chain having 1 or 2 carbon atoms; R 3 Ha-(CH 2 ) n represents an —X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, —CONH 2 represents a 5-membered ring group or a 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring. [Case 2] (In the formula, R 4 represents an aliphatic group having 9 to 23 carbon atoms; R 5 ~R 7 each independently represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may have a branched chain and which has 1 or 2 carbon atoms, or -(CH 2 ) n represents an —X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, —CONH 2represents a 5-membered ring group or a 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring. [C3] (In the formula, R 8 represents an aliphatic group having 9 to 23 carbon atoms; R 9 ~R 12 each independently represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may have a branched chain and which has 1 or 2 carbon atoms, or -(CH 2 ) n represents an —X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, —CONH 2 represents a 5-membered ring group or a 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring.
5. A composition described in any one of claims 1 to 4, wherein the sucrose ester is at least one selected from the group consisting of sucrose laurate, sucrose myristate, sucrose palmitate and sucrose stearate.
6. A method for preventing contamination of the skin or hair surface, comprising a film formation step of forming a film on the skin or hair surface, the film consisting of a composition containing a lipid peptide type compound in which a lipid portion consisting of an aliphatic group having 10 to 24 carbon atoms is bound to a peptide portion formed by repeating at least two or more identical or different amino acids, and a sucrose ester.
7. The method according to claim 6, characterized in that the lipid peptide type compound comprises at least one of the compounds represented by the following formulas (1) to (3) or pharma- ceutically usable salts thereof. [C4] (In the formula, R 1 represents an aliphatic group having 9 to 23 carbon atoms; R 2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, which may have a branched chain having 1 or 2 carbon atoms; R 3 teeth-( CH 2 ) nrepresents an —X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, —CONH 2 represents a 5-membered ring group or a 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring. [C5] (In the formula, R 4 represents an aliphatic group having 9 to 23 carbon atoms; R 5 ~R 7 each independently represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may have a branched chain and which has 1 or 2 carbon atoms, or -(CH 2 ) n represents an —X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, —CONH 2 represents a 5-membered ring group or a 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring. [C6] (In the formula, R 8 represents an aliphatic group having 9 to 23 carbon atoms; R 9 ~R 12 each independently represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may have a branched chain and which has 1 or 2 carbon atoms, or -(CH 2 ) n represents an —X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, —CONH 2 represents a 5-membered ring group or a 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring.
8. A method for preventing the adhesion of dust, pollen, particulate matter, mites (including corpses), gaseous substances, or odorous substances to the skin or hair surface, comprising a film formation step of forming a film on the skin or hair surface, the film consisting of a composition containing a lipid peptide type compound in which a lipid portion consisting of an aliphatic group having 10 to 24 carbon atoms is bound to a peptide portion formed by repeating at least two or more identical or different amino acids, and a sucrose ester.
9. The method according to claim 8, characterized in that the lipid peptide type compound comprises at least one of the compounds represented by the following formulas (1) to (3) or pharma- ceutically usable salts thereof. [C7] (In the formula, R 1 represents an aliphatic group having 9 to 23 carbon atoms; R 2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, which may have a branched chain having 1 or 2 carbon atoms; R 3 teeth-( CH 2 ) n represents an —X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, —CONH 2 represents a 5-membered ring group or a 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring. [C8] (In the formula, R 4 represents an aliphatic group having 9 to 23 carbon atoms; R 5 ~R 7 each independently represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may have a branched chain and which has 1 or 2 carbon atoms, or -(CH 2 ) n represents an —X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, —CONH 2 represents a 5-membered ring group or a 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring. [C9] (In the formula, R 8 represents an aliphatic group having 9 to 23 carbon atoms; R 9 ~R 12 each independently represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may have a branched chain and which has 1 or 2 carbon atoms, or -(CH 2 ) n represents an —X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, —CONH 2represents a 5-membered ring group or a 6-membered ring group which may have 1 to 3 nitrogen atoms, or a fused heterocyclic group composed of a 5-membered ring and a 6-membered ring.
10. A composition for promoting skin penetration, comprising a lipid peptide type compound in which a lipid portion consisting of an aliphatic group having 10 to 24 carbon atoms is bound to a peptide portion formed by repeating at least two or more identical or different amino acids, and a sucrose ester.
11. A method for promoting skin penetration, comprising a film formation step of forming a film on the skin surface or hair surface, the film being composed of a composition containing a lipid peptide type compound having a lipid portion consisting of an aliphatic group having 10 to 24 carbon atoms and a peptide portion formed by repeating at least two or more identical or different amino acids bound thereto, and a sucrose ester.
12. The composition according to claim 2, wherein the surface of the coating has a roughness, the average surface roughness being 3 nm to 500 nm.
